.png)
COVID-19 Evidence Reviews
as of 5/24/22
Today's Feature
|
5/19/2022 |
The COVID-19 Treatment Guidelines Panel has revised the Ritonavir-Boosted Nirmatrelvir (Paxlovid) section with a focus on drug-drug interactions. | |
= living reviewA review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
5/24/22
|
Liana P, Liberty IA, Murti K, et al. | Immunol Res
Aim: To summarize studies on the role of NETs in determining the prognosis of COVID-19 patients.
|
|
|
5/24/22
|
Panagouli ED, Thirios AC, Psaltopoulou T, et al. | EMBnet
Aim: To evaluate special features and probable correlations between symptoms, laboratory findings, treatment, and outcomes of COVID-19 in children and adolescents.
|
|
|
5/24/22
|
Chen J, Zhang SX, Yin A, et al. | J Glob Health
Aim: To summarize the prevalence of anxiety, depression, distress, insomnia, and PTSD in the adult population during the first year of the COVID pandemic in developing countries.
|
|
|
5/24/22
|
Pacheco JA, Molena KF, Martins CROG, et al. | Bull Natl Res Cent
Aim: To critically assess the clinical evidence on the use of photobiomodulation (PBMT) and antimicrobial photodynamic therapy (aPDT) for the treatment of oral lesions in patients infected with Sars-Cov-2.
|
|
|
5/24/22
|
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/24/22
|
Lee TC, Murthy S, Del Corpo O, et al. | Clin Microbiol Infect
Aim: To evaluate the role of remdesivir for hospitalized inpatients as a function of oxygen requirements.
|
|
|
5/24/22
|
Barberis N, Cannavò M, Cuzzocrea F, et al. | Clin Neuropsychiatry
Aim: To carry out a comprehensive investigation of suicide risk factors during the current COVID-19 pandemic.
|
|
|
5/24/22
|
Huang JA, Hartanti IR, Colin MN, et al. | Digit Health
Aim: To review various artificial intelligence-based telemedicine research during the COVID-19 outbreak and proposes a framework for developing telemedicine powered by artificial intelligence to monitor progression in COVID-19 patients during isolation at home.
|
|
|
5/24/22
|
Michailidou D, Stavridou A, Panagouli ED, et al. | EMBnet
Aim: To summarize current evidence on vertical transmission rates, maternal, perinatal and neonatal outcomes and mode of delivery in pregnancies affected by COVID-19.
|
|
|
5/24/22
|
O'Mahoney LL, Highton PJ, Kudlek L, et al. | Diabetes Obes Metab
Aim: To identify, appraise and synthesise available evidence on the impact of the pandemic on glycaemic control in people with diabetes. RECENTLY UPDATED
|
|
|
5/24/22
|
Tabatabaeizadeh SA | Eur J Med Res
Aim: To evaluate the effect of zinc supplementation on COVID-19 mortality.
|
|
|
5/23/22
|
Talukder A, Razu SR, Alif SM, et al. | J Multidiscip Healthc
Aim: To evaluate the association between symptoms and severity of disease in adult patients with confirmed COVID-19.
|
|
|
5/23/22
|
Lee CJ, Woo W, Kim AY, et al. | J Med Virol
Aim: To provide a comparative meta-analysis and systematic review of the risk and clinical outcomes of COVID-19 infection between fully vaccinated and unvaccinated groups.
|
|
|
5/23/22
|
Kesheh MM, Shavandi S, Haeri Moghaddam N, et al. | Virol J
Aim: To review the evidence on the effectiveness of herbal compounds against coronavirus family, which may have the potential in treating COVID19 infection.
|
|
|
5/23/22
|
Castanares-Zapatero D, Chalon P, Kohn L, et al. | Ann Med
Aim: To conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID.
|
|
|
5/23/22
|
Zuin M, Rigatelli G, Bilato MJ, et al. | Vascular
Aim: To assess prevalence and prognostic implications of pre-existing peripheral artery disease (PAD) in patients infected by the SARS-CoV-2.
|
|
|
5/23/22
|
Kudhail K, Thompson J, Mathews V, et al. | Int J Infect Dis
Aim: To describe the prevalence of risks of bias in randomised trials of therapeutic interventions for COVID-19.
|
|
|
5/23/22
|
Kim H, Hughes E, Cavanagh A, et al. | PLoS One
Aim: To conduct a mixed methods systematic review on the impacts of the COVID-19 pandemic on the health of people who experience imprisonment. RECENTLY UPDATED
|
|
|
5/20/22
|
Keskin AU, Ciragil P, Topkaya AE | Int J Microbiol
Aim: To collect and analyse current evidence on real-world performance based on clinical accuracy of instrument-read rapid antigen diagnostic tests (Ag-IRRDTs) for SARS-CoV-2 identification. RECENTLY UPDATED
DIAGNOSTICS
|
|
|
5/20/22
|
Lee KH, Li H, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To describe the clinical and laboratory characteristics of MIS-C.
|
|
|
5/20/22
|
Clinical prognosis of coronavirus disease 2019 in children and vitamin D levels: a systematic review
Alvares MA, Ribas BHB, Miranda GB, et al. | Rev Assoc Med Bras
Aim: To correlate 25(OH)D levels with the clinical prognosis of pediatric patients diagnosed with COVID-19.
|
|
|
5/20/22
|
Javadinia SA, Alizadeh K, Mojadadi MS, et al. | Front Endocrinol
Aim: To assesse the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome, with severity of COVID-19 infection and side effects following COVID-19 vaccination as the secondary outcomes.
|
|
|
5/20/22
|
Alahyari S, Moradi M, Rajaeinejad M, et al. | Expert Rev Hematol
Aim: To comprehensively assess the post-COVID hematologic complications in patients.
|
|
|
5/19/22
|
Ackah M, Ameyaw L, Gazali Salifu M, et al. | PLoS One
Aim: To review the acceptance rate and possible reasons for COVID-19 vaccine non-acceptance/hesitancy amongst HCWs in Africa. RECENTLY UPDATED
INFECTION CONTROL
|
|
|
5/19/22
|
Pandey R, Rai D, Tahir MW, et al. | Arch Med Sci Atheroscler Dis
Aim: To review the evidence on the comorbidities and symptoms of adult patients with coronavirus disease 2019 (COVID-19) to evaluate comorbidities, symptoms, and severity.
|
|
|
5/18/22
|
Lan SH, Lai CC, Chang SP, et al. | Expert Rev Clin Pharmacol
Aim: To investigate the clinical efficacy and safety of favipiravir for patients with mild-to-critical COVID-19.
|
|
|
5/17/22
|
Sofizan NMFBN, Rahman AFBA, Soon LP, et al. | Egypt J Forensic Sci
Aim: To summarize the autopsy findings related to COVID-19 death.
|
|
|
5/17/22
|
Péterfi A, Mészáros Á, Szarvas Z, et al. | Physiol Int
Aim: To review the evidence on the relationship of comorbidities and mortality due to Coronavirus Disease 2019 (COVID-19) among the elderly population.
|
|
|
5/17/22
|
Mayra ST, Kandiah J, McIntosh CE | Psychol Sch
Aim: To synthesize the existing literature on how COVID?19 impacted K?12 students' eating patterns, physical activity, and sleep in the United States.
|
|
|
5/17/22
|
Meng X, Wang J, Sun J, et al. | Front Neurol
Aim: To examine whether COVID-19 causes an increased incidence of SSNHL and the clinical characteristics of patients with COVID-19-related SSNHL.
|
|
|
5/17/22
|
Zareei M, Tabanejad Z, Oskouie F, et al. | J Educ Health Promot
Aim: To review the studies on burnout among nurses during the COVID-19 epidemic.
|
|
|
5/17/22
|
Alshammary AF, Alsughayyir JM, Alharbi KK, et al. | Front Med
Aim: To analyze T-cell subsets (CD4/CD8) and IL-10 in severe and fatal cases of COVID-19. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Riccò M, Ranzieri S, Peruzzi S, et al. | Acta Biomed
Aim: To assess available evidence and to explore the reliability of antigenic tests in the management of the SARS-CoV-2 pandemic.
|
|
|
5/16/22
|
Afzal S, Nasir M | J Coll Physicians Surg Pak
Aim: To assess risk factors and case fatality in COVID-19 cases with aspergillosis or mucormycosis.
|
|
|
5/16/22
|
Lee B, Ashcroft T, Agyei-Manu E, et al. | J Glob Health
Aim: To assess whether the common clinical features of COVID-19 have changed to the point that the criteria used to identify both COVID-19 and influenza in surveillance programs needs to be altered.
|
|
|
5/16/22
|
Mastan S, Hodhody G, Sajid M, et al. | Geriatr Orthop Surg Rehabil
Aim: To assess the early mortality rate of hip fracture patients in the UK, with and without COVID-19 infection.
|
|
|
5/16/22
|
Toro-Huamanchumo CJ, Benites-Meza JK, Mamani-García CS, et al. | J Clin Med
Aim: To assess the efficacy of colchicine in COVID-19 patients. RECENTLY UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/16/22
|
Vaseghi N, Sharifisooraki J, Khodadadi H, et al. | Mycoses
Aim: To evaluate and estimate the global prevalence of coronavirus-associated C. auris infection (CACa). RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Lv J, Wu H, Xu J, et al. | Infect Dis Poverty
Aim: To pool the evidence on the immunogenicity and safety of heterologous versus homologous prime-boost vaccination schedule.
|
|
|
5/16/22
|
Cho K, Park S, Kim EY, et al. | J Med Virol
Aim: To compare the efficacy of COVID-19 vaccination in patients with solid tumor, hematologic malignancy, autoimmune disease, inflammatory bowel disease, and patients who received transplantation or dialysis.
|
|
|
5/16/22
|
Altobelli E, Angeletti PM, Marzi F, et al. | J Clin Med
Aim: To robustly quantify admission trends of patients with ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI) during the first wave of the pandemic and to characterize on a large basis the risk profile and early prognosis.
|
|
|
5/16/22
|
Landoni G, Belloni O, Russo G, et al. | J Clin Med
Aim: To identify all the literature published and all the currently ongoing trials on volatile anesthetics in COVID-19 patients to enlighten the pros/cons of their role in this setting.
|
|
|
5/16/22
|
Nappi F, Bellomo F, Avtaar Singh SS | J Clin Med
Aim: To investigate the role of inflammatory pathways, highlighting several culprits including neutrophil extracellular traps (NETs) which have since been extensively investigated.
|
|
|
5/16/22
|
Juneau CE, Pueyo T, Bell M, et al. | Syst Rev
Aim: To provide a comprehensive summary of the evidence on past pandemic controls, with a focus on cost-effectiveness.
|
|
|
5/16/22
|
Teschke R, Méndez-Sánchez N, Eickhoff A | Int J Mol Sci
Aim: To analyze published reports on conventional drugs and their role in causing liver injury among COVID-19 patients.
|
|
|
5/16/22
|
Ruvinsky S, Voto C, Roel M, et al. | Front Pediatr
Aim: To describe the clinical course, laboratory findings, epidemiology, treatment, and use of resources of MIS-C in children from LAC. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Santana LADM, Vieira WA, Gonçalo RIC, et al. | J Stomatol Oral Maxillofac Surg
Aim: To better understand the relationship between COVID-19 infection and oral lesions. RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Carmassi C, Pacciardi B, Gravina D, et al. | Int J Environ Res Public Health
Aim: To evaluate and gather the scientific evidence on pharmacologic handling during delirium in COVID-19 patients to provide practical recommendations on the optimal management of psychotropic medication in these kinds of patients.
|
|
|
5/16/22
|
Fugazzaro S, Contri A, Esseroukh O, et al. | Int J Environ Res Public Health
Aim: To explore the effectiveness of rehabilitation interventions for adult patients with PACS by reporting the main changes in outcomes after the experimental interventions. RECENTLY UPDATED
|
|
|
5/16/22
|
Caini S, Martinoli C, La Vecchia C, et al. | Int J Environ Res Public Health
Aim: To estimate SARS-CoV-2 infections detected in schools comparing positive rates found from screening and contact tracing methods, to compare infectivity and susceptibility of students compared to school staff, and to investigate reasons of between-study heterogeneity.
|
|
|
5/16/22
|
Carvalho S, Coelho CG, Kluwe-Schiavon B, et al. | Int J Environ Res Public Health
Aim: To systematically review the impact of the early stages COVID-19 pandemic on people with pre-existing psychiatric disorders.
|
|
|
5/16/22
|
Dellafiore F, Arrigoni C, Nania T, et al. | Acta Biomed
Aim: To synthesize the current evidence on the impact of the COVID-19 pandemic on caregivers' mental health. RECENTLY UPDATED
MENTAL HEALTH
|
|
|
5/16/22
|
Chen F, Tian Y, Zhang L, et al. | Int J Infect Dis
Aim: To (1) assess the prevalence of pediatric COVID-19 in family clusters; (2) estimate the household secondary attack rate of children in different periods and variants; (3) compare the transmissibility of SARS-CoV-2 in different age groups and explore its potential determinants. RECENTLY UPDATED
INFECTION CONTROL
|
|
|
5/16/22
|
Mani A, Ojha V | Ann Vasc Surg
Aim: To systematically review thromboembolic events reported after Covid-19 vaccination.
|
|
|
5/13/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on emerging SARS-CoV-2 variants.
|
|
|
5/12/22
|
Moneer O, Daly G, Skydel JJ, et al. | BMJ
Aim: To systematically identify, match, and compare treatment effects and study demographics from individual or meta-analysed observational studies and randomized controlled trials (RCTs) evaluating the same covid-19 treatments, comparators, and outcomes.
CANDIDATE THERAPEUTICS
|
|
|
5/12/22
|
Tavares-Júnior JWL, de Souza ACC, Borges JWP, et al. | Cortex
Aim: To determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD). RECENTLY UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/12/22
|
Prasad S, Kalafat E, Blakeway H, et al. | Nat Commun
Aim: To review the effects of COVID-19 vaccination in pregnancy, and on vaccine effectiveness in pregnancy. RECENTLY UPDATED
INFECTION CONTROL
|
|
|
5/11/22
|
Chang Y, Bai M, You Q | Biomed Res Int
Aim: To investigate the association between interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
5/11/22
|
Jiang L, Tang K, Irfan O, et al. | Curr Pediatr Rep
Aim: To investigate and synthesize evolving evidence on its clinical characteristics, management, and outcomes in pediatric patients.
CLINICAL CHARACTERISTICS
|
|
|
5/11/22
|
Kolahdouzan K, Chavoshi M, Bayani R, et al. | Int J Radiat Oncol Biol Phys
Aim: To review studies incorporating WLI for the treatment of COVID-19 pneumonia. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/11/22
|
Verleye A, Wijtvliet V, Abrams S, et al. | Nephrol Dial Transplant
Aim: To compare the antibody response after two-dose mRNA-1273 versus BNT162b2 vaccination in solid organ transplant (SOT) recipients. UPDATED
INFECTION CONTROL
|
|
|
5/10/22
|
Weng Y, Yi GY | J Med Virol
Aim: To provide sensible estimates of the mean incubation time of COVID-19 by capitalizing on available estimates reported in the literature and exploring different ways to accommodate heterogeneity involved in the reported studies.
CLINICAL CHARACTERISTICS
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/2/22
|
Chow KW, Pham NV, Ibrahim BM, et al. | Dig Dis Sci
Aim: To analyze every published case of AIH and reviewed their characteristic findings, treatment, and outcomes.
INFECTION CONTROL
|
|
|
5/2/22
|
Rahmani A, Dini G, Leso V, et al. | Med Lav
Aim: To review the evidence on the duration of SARS-CoV-2 shedding and infectivity in the working age population.
INFECTION CONTROL
|
|
|
5/2/22
|
Umesh A, Pranay K, Pandey RC, et al. | Infection
Aim: To perform a rapid review and evidence mapping of systemic complications and symptoms of long-COVID and underlying pathophysiological mechanisms.
|
|
|
5/2/22
|
Madewell ZJ, Yang Y, Longini IM Jr, | JAMA Netw Open
Aim: To evaluate how reported household SARs changed over time and whether SARs varied by viral variant and index case and contact vaccination status.
INFECTION CONTROL
|
|
|
5/2/22
|
Doceda MV, Gavriiloglou M, Petit C, et al. | Oral Health Prev Dent
Aim: To evaluate the potential association of COVID-19 infection with oral health.
CLINICAL CHARACTERISTICS
|
|
|
5/2/22
|
Shahsavarinia K, Rahvar G, Soleimanpour H, et al. | Pak J Med Sci
Aim: To investigate the underlying factors causing pneumothorax, pneumomediastinum, and subcutaneous emphysema in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
5/2/22
|
McCosker LK, El-Heneidy A, Seale H, et al. | Vaccine
Aim: To identify, analyse the characteristics of, and evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless.
INFECTION CONTROL
|
|
|
5/2/22
|
Gupta S, Jawanda MK | Eur J Neurol
Aim: To evaluate the number of published cases of Bell's palsy as the only major neurological manifestation in patients with COVID-19 from March 2020 to December 2021 and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
|
|
|
5/2/22
|
Kow CS, Ramachandram DS, Hasan SS | J Cardiovasc Pharmacol
Aim: To perform a systematic review and meta-analysis to determine the effect of preadmission/prediagnosis use of CCBs on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/26/22
|
Geng H, Cao K, Zhang J, et al. | Hum Vaccin Immunother
Aim: To synthesize the attitudes and determinants in vaccination hesitancy of college students.
INFECTION CONTROL
|
|
|
4/26/22
|
Alosaimi B, AlFayyad I, Alshuaibi S, et al. | BMC Sports Sci Med Rehabil
Aim: To measure the prevalence of CV complications suffered by COVID-19 athletic patients, explore the outcomes, optimal approaches to diagnoses, and safe return-to-play considerations.
CLINICAL CHARACTERISTICS
|
|
|
4/26/22
|
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/26/22
|
Deng J, Heybati K, Ramaraju HB, et al. | Infection
Aim: To assess and compare the relative efficacy and safety of anti-SARS-CoV-2 antibody regimens for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/26/22
|
Conti V, Sellitto C, Torsiello M, et al. | JAMA Netw Open
Aim: To identify DDIs that led to adverse clinical outcomes and/or adverse drug reactions in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/26/22
|
Zhang SX, Batra K, Xu W, et al. | Epidemiol Psychiatr Sci
Aim: To provide meta-analytical evidence on mental health symptoms during COVID-19 among frontline healthcare workers, general healthcare workers, the general population and university students in Latin America.
MENTAL HEALTH
|
|
|
4/26/22
|
Sakur FJ, Ward K, Khatri NN, et al. | JMIR Hum Factors
Aim: To review how self-care behaviours have changed for people with chronic conditions during the COVID-19 pandemic, and what technology they have adopted to manage their conditions during that period. UPDATED
MENTAL HEALTH
|
|
|
4/26/22
|
Romeo FJ, Barbagelata L, Chiabrando JG, et al. | Am J Ther
Aim: To conduct an updated systematic review and meta-analysis of randomized clinical trials to assess a potential benefit of colchicine in hospitalized patients with COVID-19 infection. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/22/22
|
Luo S, Liang Y, Wong THT, et al. | Int J Epidemiol
Aim: To summarize modifiable factors for coronavirus disease 2019 (COVID-19) suggested by Mendelian randomization studies. UPDATED
|
|
|
4/22/22
|
Giannos P, Katsikas Triantafyllidis K, et al. | Front Neurol
Aim: To screen the current literature and provide a summary of the reported cases of SARS-CoV-2 infected patients presenting with persistent hiccups.
CLINICAL CHARACTERISTICS
|
|
|
4/21/22
|
Sankova MV, Nikolenko VN, Oganesyan MV, et al. | Curr Drug Targets
Aim: To evaluate the pathogenetic relationship between gut microbiota, immunological reactivity disruption and microbiota pathologies with the new coronavirus infection's course in order to substantiate the use of current drugs correcting gut microbiota during the SARS-CoV-2 pandemic.
|
|
|
4/21/22
|
Kastora S, Patel M, Carter B, et al. | Endocrinol Diabetes Metab
Aim: To analyse the collective and geographically stratified mortality, ICU admission, ventilation requirement, illness severity and discharge rate amongst patients with diabetes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/21/22
|
Vinayagamoorthy K, Pentapati KC, Prakash H | Mycoses
Aim: To address the prevalence, underlying diseases, iatrogenic risk factors, treatment and outcome of C. auris infections in COVID-19 patients.
|
|
|
4/19/22
|
Crawshaw AF, Farah Y, Deal A, et al. | Lancet Infect Dis
Aim: Exploring barriers and facilitators of vaccine uptake (categorised using the 5As taxonomy: access, awareness, affordability, acceptance, activation) and sociodemographic determinants of undervaccination among migrants in the EU and European Economic Area, the UK, and Switzerland.
INFECTION CONTROL
|
|
|
4/19/22
|
Chen C, Haupert SR, Zimmermann L, et al. | J Infect Dis
Aim: To examine the worldwide prevalence of post COVID-19 condition.
CLINICAL CHARACTERISTICS
|
|
|
4/19/22
|
Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. | Arch Iran Med
Aim: To evaluate the role of regulatory T cells (Tregs) as one of the main cells that maintain immune homeostasis.
CLINICAL CHARACTERISTICS
|
|
|
4/18/22
|
Haghshomar M, Shobeiri P, Brand S, et al. | J Eat Disord
Aim: To provide a comprehensive overview of symptoms of ED and metabolic changes during the COVID-19 confinement.
MENTAL HEALTH
|
|
|
4/18/22
|
Sabaghian T, Rommasi F, Omidi F, et al. | Bratisl Lek Listy
Aim: To collate the condition and risk factors of AKI and non-AKI COVID-19 patients and to investigate AKI incidence in high-risk patients.
CLINICAL CHARACTERISTICS
|
|
|
4/18/22
|
Sulakshana S, Nayak SS, Perumal S, et al. | Anesth Essays Res
Aim: To review the evidence on the occurance of heparin-induced thrombocytopenia in COVID-19
CANDIDATE THERAPEUTICS
|
|
|
4/18/22
|
Tasoudis PT, Arvaniti CK, Adamou AT, et al. | Eur J Intern Med
Aim: To assess the efficacy of IL-6 inhibitors compared to standard of care (SOC) in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
4/18/22
|
Ling RR, Ramanathan K, Tan FL, et al. | Lancet Respir Med
Aim: To characterise the incidence of myopericarditis following COVID-19 vaccination, and compare this with non-COVID-19 vaccination.
INFECTION CONTROL
|
|
|
4/18/22
|
Lotan I, Lydston M, Levy M | J Neuroophthalmol
Aim: To summarize the available postmarketing data regarding the occurrence of neuro-ophthalmological and other ocular complications of the COVID-19 vaccines.
INFECTION CONTROL
|
|
|
4/14/22
|
Daniels NF, Burrin C, Chan T, et al. | Curr Dev Nutr
Aim: To explore the indirect effects of the first year of COVID-19 on obesity and its risk factors. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Rahmati M, Shamsi MM, Khoramipour K, et al. | Rev Med Virol
Aim: To explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the pandemic, and to evaluate the reliability of the evidence.
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Panda SK, Mishra A, Pathak M | Cureus
Aim: To analyze the clinical outcomes and SARS-CoV-2 infectivity of neonates born to SARS-CoV-2 positive mothers in India from published literature.
|
|
|
4/14/22
|
Minkove SJ, Sun J, Li Y, et al. | Rev Med Virol
Aim: To analyse studies presenting the adjusted effects specifically of ICI therapy on either survival, a severe event, or need for hospitalisation in cancer patients presenting with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/14/22
|
Yang H, Rigsby M, Zhu X, et al. | HERD
Aim: To identify factors associated with LTCF residents' COVID-19 infections and the impacts of the pandemic and the corresponding preventive measures on residents' mental health and behavioral problems.
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Ludhiadch A, Paul SR, Khan R, et al. | Int J Neurosci
Aim: To summarize the available literature on SCV-2 induced ischemic Stroke and its subtypes.
MENTAL HEALTH
|
|
|
4/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
4/14/22
|
Ortenzi M, Balla A, Botteri E, et al. | Minerva Surg
Aim: To offer a comprehensive overview of the most important recommendations by the International Guidelines about general surgery.
INFECTION CONTROL
|
|
|
4/14/22
|
Ghasemi S, Harmooshi NN, Rahim F | Diagn Pathol
Aim: To investigate the eligible studies for the sensitivity and specificity of rapid tests and explore the factors that influence the result to help better diagnose COVID-19 infection.
DIAGNOSTICS
|
|
|
4/14/22
|
Manothummetha K, Chuleerarux N, Sanguankeo A, et al. | JAMA Netw Open
Aim: To summarize current evidence on vaccine responses and identify risk factors for diminished humoral immune response in recipients of SOT.
|
|
|
4/14/22
|
Umbrello M, Venco R, Antonucci E, et al. | Minerva Anestesiol
Aim: To investigate the incidence, risk factors and clinical outcomes of barotrauma among critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Modica G, Bianco M, Sollazzo F, et al. | Int J Environ Res Public Health
Aim: To assess the event rates of myocarditis detected by Cardiac Magnetic Resonance (CMR) in athletes who recovered from COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Ulbrichtova R, Svihrova V, Svihra J | Int J Environ Res Public Health
Aim: To evaluate the prevalence of COVID-19 vaccination among medical students worldwide. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/14/22
|
Vieira AGDS, Pinto ACPN, Garcia BMSP, et al. | J Physiother
Aim: To review the evidence on the effectiveness and safety of telerehabilitation for people with COVID-19 and post-COVID-19 conditions. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/14/22
|
Wang H, Li N, Sun C, et al. | Am J Emerg Med
Aim: To explore whether pregnancy increases the risk of adverse outcomes of COVID-19.
MENTAL HEALTH
|
|
|
4/14/22
|
Su W, Wang H, Sun C, et al. | Am J Prev Med
Aim: To assess the association between previous influenza vaccination and COVID-19 on the basis of the available evidence. UPDATED
|
|
|
4/14/22
|
Jia L, Carter MV, Cusano A, et al. | Am J Sports Med
Aim: To investigate the effect of the COVID-19 pandemic on the mental and emotional health of athletes and to identify risk factors associated with poor mental health outcomes.
INFECTION CONTROL
|
|
|
4/11/22
|
Litwinowicz K, Choroszy M, Ornat M, et al. | Sci Rep
Aim: To provide a comprehensive evaluation of the face masks and disposable FFRs effects on human physiology during low, moderate, and high-intensity activities. UPDATED
INFECTION CONTROL
|
|
|
4/11/22
|
Palaiodimou L, Stefanou MI, de Sousa DA, et al. | J Neurol
Aim: To better characterize TTS-associated CVST, along with the therapeutic and prognostic implications, compared to non-TTS–CVST cases.
INFECTION CONTROL
|
|
|
4/11/22
|
Koupaei M, Mohamadi MH, Yashmi I, et al. | J Clin Lab Anal
Aim: To evaluate the features of COVID-19 relapse patients.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Huang D, Zunong J, Li M, et al. | Curr HIV/AIDS Rep
Aim: To review the evidence on the epidemiological characteristics and clinical presentation of coinfected patients in China, as well as laboratory indicators, antiretroviral therapy status, and disease outcomes in PLHIV coinfected with CoV.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Perry J, Osman S, Wright J, et al. | PLoS One
Aim: To assess the evidence for a humoral CoP for SARS-CoV-2.
INFECTION CONTROL
|
|
|
4/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-acute sequelae of COVID-19 infection.
|
|
|
4/11/22
|
Boden I, Bernabeu MO, Dhillon B, et al. | Diabetes Res Clin Pract
Aim: To test the hypothesis that pre-existing diabetic retinopathy (DR), a microvascular disease, is a prognostic indicator for poor COVID-19 outcome in this heterogeneous population.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Chaudhry ZS, Nellessen N, Reis C, et al. | Fam Pract
Aim: To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Edilgireeva LA, Sadulaeva TA, Zakharov VV, et al. | Zh Nevrol Psikhiatr Im S S Korsakova
Aim: To assess the effect of antiplatelet therapy on the risk of thrombotic complications and disease course in SARS-COV-2 infected patients.
CANDIDATE THERAPEUTICS
|
|
|
4/11/22
|
Thornton GM, Fleck BA, Fleck N, et al. | PLoS One
Aim: To examine the effectiveness of HVAC design features in reducing virus transmission. UPDATED
INFECTION CONTROL
|
|
|
4/8/22
|
Nawabi NLA, Duey AH, Kilgallon JL, et al. | J Neurointerv Surg
Aim: To review the evidence on how COVID-19 affected stroke response times.
INFECTION CONTROL
|
|
|
4/8/22
|
Wake AD | Glob Pediatr Health
Aim: To evaluate the potential intrauterine vertical transmission of a novel SARS-CoV-2 among confirmed cases of pregnant women.
MENTAL HEALTH
|
|
|
4/8/22
|
Han P, Duan X, Zhao S, et al. | Front Public Health
Aim: To summarize and evaluate the actual psychological experience of nurses caring for patients with severe pneumonia in the ICUs during the COVID-19 pandemic.
|
|
|
4/8/22
|
Marmitt DJ | Inflammopharmacology
Aim: To select clinical trials with anti-inflammatory plants and relate the activity of these plants to inflammatory markers of SARS-CoV-2 infection.
|
|
|
4/8/22
|
Fallah-Aliabadi S, Fatemi F, Heydari A, et al. | Public Health Nurs
Aim: To identify and categorize social vulnerability indicators in the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Hopefl R, Ben-Eltriki M, Deb S | J Pharm Pharm Sci
Aim: To analyze the association of vitamin D levels with the inflammatory markers in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Rahmani AM, Azhir E, Naserbakht M, et al. | Multimed Tools Appl
Aim: To review the evidence on the application of Machine Learning (ML) methods for the detection of COVID-19.
DIAGNOSTICS
|
|
|
4/7/22
|
Naimi A, Yashmi I, Jebeleh R, et al. | J Clin Lab Anal
Aim: To review the literature reporting the COVID-19 outcomes in patients with hematological malignancies.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Fu XL, Qian Y, Jin XH, et al. | Lupus
Aim: To evaluate the epidemiology of SLE and COVID-19, to identify the clinical characteristics of SLE patients with COVID-19, to clarify the treatment of COVID-19 in SLE patients and to assess the impact of COVID-19 pandemic on SLE patients.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Yazdani A, Mirmosayyeb O, Ghaffary EM, et al. | Neurol Sci
Aim: To determine the pooled prevalence of vaccination willingness, unwillingness, and hesitancy among patients with multiple sclerosis.
INFECTION CONTROL
|
|
|
4/7/22
|
Alimoradi Z, Abdi F, Gozal D, et al. | BMJ Open
Aim: To estimate the sleep problems among pregnant women during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
4/7/22
|
Lee TC, Vigod S, Bortolussi-Courval É, et al. | JAMA Netw Open
Aim: To perform a meta-analysis of the available randomized clinical trial evidence for fluvoxamine in the outpatient management of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Bhuta S, Khokher W, Kesireddy N, et al. | Am J Ther
Aim: To investigate the efficacy of fluvoxamine in nonhospitalized patients with acute COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Fadlalla M, Ahmed M, Ali M, et al. | Curr Pharmacol Rep
Aim: To review and summarize research of FDA-approved drugs repurposed against SARS-CoV-2 virus.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, et al. | J Clin Lab Anal
Aim: To evaluate the prevalence of neurological complications arises from SARS-CoV-2 and assess the mortality rate from neurological complications.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Yasmin F, Najeeb H, Moeed A, et al. | PLoS One
Aim: To evaluate the safety profile of colchicine in COVID-19 patients using the gold-standard randomised-control trials.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
James D, Jena A, Bharath PN, et al. | Dig Liver Dis
Aim: To review the evidence on the various adverse events following COVID-19 vaccination in patients with IBD in order to inform the clinicians and patients regarding the (lack of) risks) of COVID vaccination.
INFECTION CONTROL
|
|
|
4/7/22
|
J Devoe D, Han A, Anderson A, et al. | Int J Eat Disord
Aim: To synthesize the impact of the COVID-19 pandemic on individuals with EDs. UPDATED
MENTAL HEALTH
|
|
|
4/6/22
|
Gupta AK, Leslie A, Hewitt JN, et al. | ANZ J Surg
Aim: To characterize outcomes of COVID-19 positive patients undergoing cardiac surgery. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/6/22
|
Bailey CJ, Gwilt M | Front Pharmacol
Aim: To review the clinical literature on clinical outcomes in metformin-treated subjects presenting with Covid-19.
CANDIDATE THERAPEUTICS
|
|
|
4/6/22
|
Theberath M, Bauer D, Chen W, et al. | SAGE Open Med
Aim: To summarize existing survey studies addressing the effects of the current COVID-19 pandemic on the mental health of children and adolescents.
MENTAL HEALTH
|
|
|
4/6/22
|
Gao Y, Bagheri N, Furuya-Kanamori L | Z Gesundh Wiss
Aim: To investigate the impact of the coronavirus lockdowns on ED symptoms severity and summarize factors associated with lockdowns that led to changes in eating disorders.
MENTAL HEALTH
|
|
|
4/6/22
|
Iheanacho CO, Eze UIH | Futur J Pharm Sci
Aim: To evaluate the clinical and laboratory features associated with BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines, to determine their immunogenicity.
INFECTION CONTROL
|
|
|
4/6/22
|
Rauniyar R, Mishra A, Kharel S, et al. | Can J Infect Dis Med Microbiol
Aim: To evaluate the optimal treatment using IVIG alone versus IVIG plus glucocorticoids.
CANDIDATE THERAPEUTICS
|
|
|
4/6/22
|
Liu M, Mei K, Tan Z, et al. | Can J Gastroenterol Hepatol
Aim: To evaluate the relationship between liver fibrosis scores and adverse outcomes in patients with COVID-19, as well as potential dose-response association. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/6/22
|
Calvert C, John J, Nzvere FP, et al. | Glob Health Action
Aim: To report the findings of a rapid systematic review of studies on levels of maternal mortality before and during the COVID-19 pandemic. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/6/22
|
Moya-Salazar J, Nuñez E, Jaime-Quispe A, et al. | Subst Abuse
Aim: To determine the frequency of substance use among Latin American HCWs.
MENTAL HEALTH
|
|
|
4/5/22
|
Ao G, Li A, Wang Y, et al. | Am J Emerg Med
Aim: To investigate the association between opioid usage and COVID-19 prognosis. UPDATED
|
|
|
4/4/22
|
Patanavanich R, Siripoon T, Amponnavarat S, et al. | Nicotine Tob Res
Aim: To explore the association between current smoking and the risk for mortality due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Fomenko A, Weibel S, Moezi H, et al. | Rev Med Virol
Aim: To review the evidence on RT-PCR performance in detecting infectious SARS-CoV-2. UPDATED
DIAGNOSTICS
|
|
|
4/4/22
|
Silverberg SL, Zhang BY, Li SNJ, et al. | BMC Pediatr
Aim: To identify the role of children in SARS-CoV-2 transmission to other children and adults.
INFECTION CONTROL
|
|
|
4/4/22
|
Wang Y, Kang L, Chien CW, et al. | Front Cardiovasc Med
Aim: To compare the characteristics, management, and clinical outcomes between the COVID-19 and non-COVID-19 patients concomitant STEMI. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Mondal R, Mishra S, Pillai JSK, et al. | J Family Prim Med Care
Aim: To identify the impacts of the pandemic on biomedical waste management.
|
|
|
4/4/22
|
Mohanty RR, Biswa Mohan Padhy, Meher BR | J Pharm Pharm Sci
Aim: To determine the efficacy and safety of the pulse dose methyl prednisolone in management of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/4/22
|
Len P, Iskakova G, Sautbayeva Z, et al. | Front Cardiovasc Med
Aim: To assess the association between early hemostatic parameters and infection severity.
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Yang F, Xu Y, Dong Y, et al. | Pancreatology
Aim: To determine the pooled prevalence and prognostic significance of increased pancreatic enzymes in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Mazidimoradi A, Alemzadeh E, Alemzadeh E, et al. | Life Sci
Aim: To evaluate the effect of polyunsaturated fatty acids on the prognosis of Covid-19 disease.
CANDIDATE THERAPEUTICS
|
|
|
4/4/22
|
Mirhashemi A, Khami MR, Kharazifard M, et al. | Front Public Health
Aim: To systematically review the relationship between oral habits (bruxism- temporomandibular disorders) and COVID-19 pandemic in adults and adolescents.
MENTAL HEALTH
|
|
|
4/1/22
|
van Mulukom V, Pummerer LJ, Alper S, et al. | Soc Sci Med
Aim: To provide a comprehensive overview of the available research on COVID-19 conspiracy beliefs and to synthesise this research to make it widely accessible.
INFECTION CONTROL
|
|
|
4/1/22
|
Khedr A, Al Hennawi H, Rauf I, et al. | Infez Med
Aim: To assess and compare mortality outcomes between LMICs and high-income countries (HICs).
CLINICAL CHARACTERISTICS
|
|
|
4/1/22
|
El-Qushayri AE, Mahmoud MA, Salman S, et al. | Dermatol Ther
Aim: To evaluate the safety of dupilumab use in the management of atopic dermatitis (AD) during the current pandemic regarding the risk and the hazards of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
4/1/22
|
Bhurwal A, Mutneja H, Bansal V, et al. | Aliment Pharmacol Ther
Aim: To summarize the available literature regarding the safety and effectiveness of SARS-CoV-2 vaccine in IBD.
INFECTION CONTROL
|
|
|
4/1/22
|
Yasuda H, Mayumi T, Okano H | Infection
Aim: To examine the effects of anticoagulant doses administered to patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/1/22
|
Kim DH, Kim SW, Kang M, et al. | Clin Otolaryngol
Aim: To assess the effect of topical steroids on acute-onset olfactory dysfunction in patients infected with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/1/22
|
Ma BM, Tam AR, Chan KW, et al. | Front Med
Aim: To review the evidence on the efficacy and safety of COVID-19 vaccine in patients on RRT. UPDATED
INFECTION CONTROL
|
|
|
4/1/22
|
Patterson PD, Mcilvaine QS, Nong L, et al. | J Am Coll Emerg Physicians Open
Aim: To assess the evidence regarding masking in the workplace during the initial months of the COVID?19 pandemic.
INFECTION CONTROL
|
|
|
4/1/22
|
Wang F, Ma Y, Xu S, et al. | Clin Rheumatol
Aim: To assess the risk of COVID-19 in patients with rheumatic diseases.
CLINICAL CHARACTERISTICS
|
|
|
4/1/22
|
Su Y, Rao W, Li M, et al. | Int Psychogeriatr
Aim: To provide up-to-date pooled estimates of the prevalence of social isolation and loneliness among older adults during the COVID-19 pandemic and other pandemics in the last two decades. UPDATED
MENTAL HEALTH
|
|
|
4/1/22
|
Figueiredo EAB, Silva WT, Tsopanoglou SP, et al. | Rev Soc Bras Med Trop
Aim: To discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization.
CLINICAL CHARACTERISTICS
|
|
|
3/31/22
|
Liu G, Chen Y, Runa A, et al. | Eur Radiol
Aim: To provide an updated overview of the diagnostic performance of CO-RADS in COVID-19, with a focus on the possible practical application of CO-RADS.
DIAGNOSTICS
|
|
|
3/31/22
|
Diallo A, Carlos-Bolumbu M, Diallo MH, et al. | Z Gesundh Wiss
Aim: To optimize vaccination strategy, evidence on vaccine efficacy against COVID-19 is needed. UPDATED
INFECTION CONTROL
|
|
|
3/31/22
|
Abdel-Gawad M, Zaghloul MS, Abd-Elsalam S, et al. | Antiinflamm Antiallergy Agents Med Chem
Aim: To assess the prevalence of post-COVID-19 manifestations.
CLINICAL CHARACTERISTICS
|
|
|
3/31/22
|
de Oliveira YLM, de Sa Resende A, Martins-Filho PR, et al. | Inflammopharmacology
Aim: To evaluate the expression of TREM-1 in patients with COVID-19 and other viral pneumonias compared to healthy individuals.
CLINICAL CHARACTERISTICS
|
|
|
3/31/22
|
Hong S, Wang H, Zhang Z, et al. | Steroids
Aim: To evaluate the efficacy and safety of methylprednisolone in the treatment of patients with COVID-19 compared with no corticosteroids therapy.
CANDIDATE THERAPEUTICS
|
|
|
3/30/22
|
Zheng W, Sun HL, Cai H, et al. | J Affect Disord
Aim: To evaluate the efficacy and safety of adjunctive antidepressants for COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/30/22
|
Yu SY, Koh DH, Choi M, et al. | Emerg Microbes Infect
Aim: To investigate the efficacy and safety of interleukin-6 (IL-6) receptor antagonists with standard care treatment in patients with coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/30/22
|
Almamlouk R, Kashour T, Obeidat S, et al. | Clin Microbiol Infect
Aim: To better understand the pathologic cardiac findings in COVID-19 patients at the time of postmortem evaluation.
CLINICAL CHARACTERISTICS
|
|
|
3/30/22
|
Zuin M, Bilato C, Quadretti L, et al. | G Ital Cardiol
Aim: To determine the in-hospital incidence of acute PE, based on Italian studies published on this issue.
CLINICAL CHARACTERISTICS
|
|
|
3/30/22
|
Kim AY, Woo W, Yon DK, et al. | Int J Infect Dis
Aim: To meta-analyze the clinical manifestations, diagnosis, treatment, and mortality of vaccine-induced immune thrombotic thrombocytopaenia (VITT) after adenoviral vector vaccination.
INFECTION CONTROL
|
|
|
3/28/22
|
Whited N, Cervantes J | Breastfeed Med
Aim: To investigate the presence of antibodies to SARS-CoV-2 in human breast milk after vaccination.
INFECTION CONTROL
|
|
|
3/28/22
|
Asiimwe IG, Pushpakom SP, Turner RM, et al. | Br J Clin Pharmacol
Aim: To review the evidence on cardiovascular drug exposure and COVID-19 clinical outcomes.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Beran A, Mhanna M, Srour O, et al. | Clin Nutr ESPEN
Aim: To provide a quantitative assessment of the clinical significance of micronutrient supplements in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/28/22
|
García H, Allende-López A, Morales-Ruíz P, et al. | Arch Med Res
Aim: To conduct a systematic review of the literature on published studies of COVID-19 in newborns with a positive RT–PCR test.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Sriwastava S, Sharma K, Khalid SH, et al. | Brain Sci
Aim: To discern CNS and PNS manifestations following the COVID-19 vaccine to help produce methods to mitigate them.
INFECTION CONTROL
|
|
|
3/28/22
|
Patwary MM, Alam MA, Bardhan M, et al. | Vaccines
Aim: To estimate COVID-19 vaccine acceptance and hesitance rates among the people of LMICs.
INFECTION CONTROL
|
|
|
3/28/22
|
Co M, Wong PCP, Kwong A | Cancer Treat Res Commun
Aim: To evaluate the best available evidence of axillary lymphadenopathy after COVID-19 vaccination.
INFECTION CONTROL
|
|
|
3/28/22
|
Alboksmaty A, Beaney T, Elkin S, et al. | Lancet Digit Health
Aim: To assess the effectiveness and safety of the use of pulse oximetry in the remote monitoring of patients at home with COVID-19. UPDATED
|
|
|
3/28/22
|
Gao P, Cai S, Liu Q, et al. | Vaccines
Aim: To evaluate the effectiveness and safety of SARS-CoV-2 vaccines in children and adolescents.
INFECTION CONTROL
|
|
|
3/28/22
|
Ghazy RM, Ashmawy R, Hamdy NA, et al. | Vaccines
Aim: To assess the efficacy and effectiveness of COVID-19 vaccines to prevent mortality and reduce the risk of developing severe disease after the 1st and 2nd doses.
INFECTION CONTROL
|
|
|
3/28/22
|
Garcia-Sanchez A, Peña-Cardelles JF, Ruiz S, et al. | J Clin Med
Aim: To evaluate the efficacy of different mouthwashes on the reduction of salivary viral load of SARS-CoV-2 in COVID-19 positive patients confirmed with RT-PCR tests as pre-procedural rinses.
INFECTION CONTROL
|
|
|
3/28/22
|
Fabbri L, Moss S, Khan FA, et al. | Thorax
Aim: To assess the proportion of chest CT scans and pulmonary function tests consistent with parenchymal lung disease in the follow-up of people hospitalised with COVID-19 and viral pneumonitis.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Maglietta G, Diodati F, Puntoni M, et al. | J Clin Med
Aim: To identify, in patients who had been hospitalized for COVID-19, which factors already present or emerging during hospitalization, were associated with an increased risk of exhibiting new or persisting symptoms. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Gentile F, Bocci T, Coppola S, et al. | Biomedicines
Aim: To discuss current clinical and pre-clinical data on the relationship between the lung and brain during COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
De Rose DU, Salvatori G, Dotta A, et al. | Viruses
Aim: To summarize current knowledge about maternal and neonatal outcomes following COVID-19 vaccination during pregnancy and breastfeeding.
INFECTION CONTROL
|
|
|
3/28/22
|
Riccò M, Ferraro P, Peruzzi S, et al. | Microorganisms
Aim: To summarize the available data about the risk of co-infections SARS-CoV-2–Legionella, specifically focusing on their prevalence, risk factors, and two main outcomes—ICU admission and case fatality ratio (CFR).
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Li S, Ren J, Hou H, et al. | Neurol Sci
Aim: To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Batteux E, Mills F, Jones LF, et al. | Vaccines
Aim: To identify and evaluate the effectiveness of interventions which can increase COVID-19 vaccine uptake. UPDATED
INFECTION CONTROL
|
|
|
3/28/22
|
Furnica C, Chistol RO, Chiran DA, et al. | Diagnostics
Aim: To evaluate the impact of the early COVID-19 pandemic on the presentation, management, and prognosis of STEMI patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Fatima K, Almas T, Lakhani S, et al. | Trop Med Infect Dis
Aim: To address the relationship between the use of PPI and the severity of COVID-19 infection.
INFECTION CONTROL
|
|
|
3/28/22
|
Bania A, Pitsikakis K, Mavrovounis G, et al. | J Pers Med
Aim: To summarize the most recent evidence regarding the therapeutic role of vitamin D on severe COVID-19 outcomes (length of hospital stay, mechanical ventilation, mortality) in adult populations. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/28/22
|
Decyk A, Kobylinska M, Antosik K, et al. | Rocz Panstw Zakl Hig
Aim: To review the current literature on the influence and importance of vitamin D levels on the course of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
3/25/22
|
Seirafianpour F, Pourriyahi H, Mesgarha MG, et al. | Dermatol Ther
Aim: To review the evidence on the dermatologic side effects of COVID-19 vaccinations.
INFECTION CONTROL
|
|
|
3/25/22
|
Muthuka JK, Kiptoo M, Oluoch K, et al. | JMIR Pediatr Parent
Aim: To examine the relationship between pregnancy status and the clinical COVID -19 severity characterized by cytokine storm. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/25/22
|
Jefferson L, Golder S, Heathcote C, et al. | Br J Gen Pract
Aim: To synthesise international evidence exploring the impact of COVID-19 on primary care doctors' mental health and wellbeing, and identify risk factors associated with their psychological wellbeing during this time.
MENTAL HEALTH
|
|
|
3/25/22
|
Beran A, Srour O, Malhas SE, et al. | Respir Care
Aim: To evaluate the effect of HFNC vs. NIV in COVID-19-related AHRF.
CANDIDATE THERAPEUTICS
|
|
|
3/25/22
|
He Y, Liu N, Zhuang X, et al. | Ther Adv Respir Dis
Aim: To compare the effectiveness and value of high-flow nasal cannula (HFNC) with noninvasive ventilation (NIV) for COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/25/22
|
Tan CJ, Tan BKJ, Tan XY, et al. | Laryngoscope
Aim: To review the evidence on the pathogenesis of COVID-19 olfactory dysfunction.
CLINICAL CHARACTERISTICS
|
|
|
3/25/22
|
Mutua V, Henry BM, Csefalvay CV, et al. | Acta Biomed
Aim: To explore the clinical benefits and safety of tocilizumab in addition to standard of care (SOC) in treating patients with coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/25/22
|
Helman SN, Adler J, Jafari A, et al. | Allergy Asthma Proc
Aim: To review the evidence on the medical and procedural treatment options for PVOD.
CANDIDATE THERAPEUTICS
|
|
|
3/24/22
|
Bhakta S, Erben Y, Sanghavi D, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To assess the association between race and VTE in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
3/24/22
|
Bitterman A, Martins CP, Cices A, et al. | JAMA Netw Open
Aim: To evaluate the association between regional prevalence of strongyloidiasis and ivermectin trial results for the outcome of mortality by testing the hypothesis that strongyloidiasis prevalence interacts with the RR of mortality.
CANDIDATE THERAPEUTICS
|
|
|
3/24/22
|
Jeon SR, Kang JW, Ang L, et al. | Integr Med Res
Aim: To create an evidence map which includes information for the CAM interventions according to what those interventions have strong evidence and those that need further testing.
CANDIDATE THERAPEUTICS
|
|
|
3/24/22
|
Farsi Y, Tahvildari A, Arbabi M, et al. | Front Cell Infect Microbiol
Aim: To evaluate the composition of gut microbiota in COVID-19 patients compared with healthy individuals.
CLINICAL CHARACTERISTICS
|
|
|
3/24/22
|
Alimoradi Z, Ohayon MM, Griffiths MD, et al. | BJPsych Open
Aim: To synthesize empirical evidence to understand fear of COVID-19 and its associations with mental health-related problems during this pandemic period. UPDATED
|
|
|
3/24/22
|
Seyferth AV, Wood SM, Kane RL, et al. | Plast Reconstr Surg
Aim: To quantify the prevalence of ethical discussions and representation of the four ethical principles in COVID-19 research, and to identify which principles and topics are underrepresented across scientific disciplines.
|
|
|
3/24/22
|
Tutal E, Ozaras R, Leblebicioglu H | Travel Med Infect Dis
Aim: To assess the prevalence, clinical features and outcome of autoimmune thyroid disorders triggered by COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/21/22
|
Crivelli L, Palmer K, Calandri I, et al. | Alzheimers Dement
Aim: To review the evidence on the cognitive effects of coronavirus disease 2019 (COVID-19) in adults with no prior history of cognitive impairment. UPDATED
MENTAL HEALTH
|
|
|
3/21/22
|
Wang F, Zhang L, Ding L, et al. | Front Public Health
Aim: To review the evidence on the fear among college students during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
3/21/22
|
Lee KW, Ang CS, Lim SH, et al. | HIV Med
Aim: To assess the prevalence of depression, anxiety, psychological stress, insomnia and loneliness among PLHIV during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
3/21/22
|
Allotey J, Chatterjee S, Kew T, et al. | BMJ
Aim: To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.
CLINICAL CHARACTERISTICS
|
|
|
3/21/22
|
Huang YZ, Kuan CC | Eur Rev Med Pharmacol Sci
Aim: To examine the efficacy of different types of vaccines in reducing hospitalization rates, disease severity, and mortality.
INFECTION CONTROL
|
|
|
3/18/22
|
Kumar R, Rai AK, Phukan MM, et al. | Curr Genomics
Aim: To assess the cumulative risk assessment of multiple co-morbid conditions associated with severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Ashktorab H, Russo T, Oskrochi G, et al. | Gastro Hep Adv
Aim: To analyze data from studies reporting Gastrointestinal bleeding (GIB) and/or endoscopic findings in COVID-19 patients in Western countries.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Gatti M, Rinaldi M, Bussini L, et al. | Clin Microbiol Infect
Aim: To assess the clinical outcome in SOT recipients with COVID-19 compared to general population.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Glenardi G, Chriestya F, Oetoro BJ, et al. | Acute Crit Care
Aim: To investigate the efficacy of HFNC compared to NIV in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/18/22
|
Rawal S, Tackett RL, Stone RH, et al. | Am J Obstet Gynecol MFM
Aim: To identify and synthesize what is known about COVID-19 vaccination amongst pregnant people in the U.S., including safety, effectiveness, acceptance, hesitancy, and uptake of COVID-19 vaccinations. UPDATED
INFECTION CONTROL
|
|
|
3/18/22
|
Mekonnen BD, Mengistu BA | Clin Epidemiol Glob Health
Aim: To estimate the pooled proportion of COVID-19 vaccine acceptance and its determinants in Ethiopia. UPDATED
INFECTION CONTROL
|
|
|
3/18/22
|
Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al. | Ann Med Surg
Aim: To provide a detailed account of the development of myocarditis and pericarditis following the COVID-19 vaccination UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Nikpour M, Sepidarkish M, Omidvar S, et al. | Expert Rev Vaccines
Aim: To evaluate the acceptance of a coronavirus disease 2019 (COVID-19) vaccine among pregnant women and its determinants.
INFECTION CONTROL
|
|
|
3/18/22
|
Hartwell M, Lin V, Gatewood A, et al. | J Matern Fetal Neonatal Med
Aim: To examine the inclusion of the equity reporting in SRMAs focused on pregnancy outcomes and COVID-19 using PROGRESS-Plus equity framework.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Gong X, Yuan B, Yuan Y | PLoS One
Aim: To assess the pooled incidence of pulmonary embolic events and the prognostic value of such events in intensive care unit (ICU) admissions of patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Obstetric and perinatal outcomes of pregnancies with COVID 19: a systematic review and meta-analysis
Perez-Lopez FR, Saviron-Cornudella R, Chedraui P, et al. | J Matern Fetal Neonatal Med
Aim: To compare obstetric and perinatal outcomes in laboratory-tested pregnant women for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection before delivering.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Qi X, Northridge ME, et al. | Aging Health Res
Aim: To determine the prevalence of oral health conditions in participants with COVID-19 infection and identify the associations of oral health conditions with COVID-19 related outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Zou Y, Han M, Wang J, et al. | Ann Transl Med
Aim: To compare the mortality risk of frail vs. non-frail hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Jaiswal V, Almas T, Peng Ang S, et al. | Ann Med Surg
Aim: To find the symptoms, risk factors, clinical findings, and outcomes in patient of COVID-19 having STEMI. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Ripp T, Roer JP, et al. | BMC Psychol
Aim: To review the evidence on the association between COVID-19-related conspiracy belief and infection-preventive behavior and vaccination willingness.
INFECTION CONTROL
|
|
|
3/18/22
|
Silva A, Azevedo M, Sampaio-Maia B, et al. | J Am Dent Assoc
Aim: To assess the effectiveness of mouthrinses in reducing SARS-CoV-2 viral load. UPDATED
INFECTION CONTROL
|
|
|
3/18/22
|
Aem L, Morath LP, Burstrom B, et al. | BMC Health Serv Res
Aim: To examine the impact of facility and staff characteristics on the risk of infectious disease outbreaks in care homes.
INFECTION CONTROL
|
|
|
3/18/22
|
Kamal L, Ramadan A, Farraj S, et al. | Saudi Pharm J
Aim: To review the evidence on molnupiravir safety and anti-viral activity.
CANDIDATE THERAPEUTICS
|
|
|
3/18/22
|
Mbunge E, Batani J, Gaobotse G, et al. | Glob Health J
Aim: To identify virtual healthcare services and digital health technologies deployed in South Africa during coronavirus disease 2019 (COVID-19) and the challenges associated with their use.
INFECTION CONTROL
|
|
|
3/14/22
|
Argano C, Mallaci Bocchio R, Lo Monaco M, et al. | Int J Mol Sci
Aim: To assess the association between vitamin D supplementation and inflammatory markers in patients with diabetes; furthermore, vitamin D’s possible role in COVID-19 patients was assessed as well.
CANDIDATE THERAPEUTICS
|
|
|
3/14/22
|
Cao C, Gan X, Hu X, et al. | Aging
Aim: To evaluate the relationship between active immunotherapy and outcomes of cancer patients who had concurrent COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
3/14/22
|
Kaya T, Dilek A, Ozaras R, et al. | Travel Med Infect Dis
Aim: To evaluate COVID-19 cases presented with febrile neutropenia and provide information regarding incidence, clinical course and prognosis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/14/22
|
Chen W, Yin C, Zhong M, et al. | Ann Palliat Med
Aim: To identify studies systematically that describe the incidence and outcome of COVID-19-related pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
|
|
|
3/14/22
|
Branjerdporn G, Bowman C, Kenworthy S, et al. | Front Psychiatry
Aim: To examine the impact of past viral epidemics on staff mental health interventional responses, with a specific focus on healthcare provider response in the context of the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
3/14/22
|
Garcia-Sanchez A, Peña-Cardelles JF, Ordonez-Fernandez E, et al. | Int J Environ Res Public Health
Aim: To investigate the effectiveness of PVP-I used as a mouthwash to decrease the salivary viral load of SARS-CoV-2.
INFECTION CONTROL
|
|
|
3/14/22
|
Sharma P, Malik S, Wadhwan V, et al. | Rev Med Virol
Aim: To assess the prevalence of oral manifestations in COVID-19 confirmed individuals. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/14/22
|
Centeno-Cortez AK, Diaz-Chavez B, Santoyo-Saavedra DR, et al. | Rev Med Inst Mex Seguro Soc
Aim: To sustain with scientific evidence the importance of respiratory physiotherapy and its effects on post-acute COVID-19 adult patients.
CANDIDATE THERAPEUTICS
|
|
|
3/14/22
|
Ojo O, Ojo OO, Feng Q, et al. | Nutrients
Aim: To evaluate the effects of enteral nutrition in critically ill patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
UPDATED
|
|
|
3/11/22
|
Chen H, Shi H, Liu X, et al. | Front Med
Aim: To evaluate the effect of PR on lung impairment for patients with post-COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/11/22
|
Tao K, Tzou PL, Pond SLK, et al. | Preprints.org
Aim: To review the evidence on the in vitro activity of authorized mAbs against the Omicron variants.
|
|
|
3/11/22
|
Abdelazeem B, Awad AK, Elbadawy MA, et al. | Drug Discov Ther
Aim: To evaluate the effects of curcumin in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/10/22
|
Dao TL, Hoang VT, Colson P, et al. | J Clin Virol Plus
Aim: To determine the proportion of co-infection with influenza viruses in SARS-CoV-2 positive patients and to investigate the severity of COVID-19 in these patients.
CLINICAL CHARACTERISTICS
|
|
|
3/10/22
|
Griesel M, Wagner C, Mikolajewska A, et al. | Cochrane Database Syst Rev
Aim: To assess whether inhaled corticosteroids are effective and safe in the treatment of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/10/22
|
Jari R, Alfuraih AM, McLaughlan JR | J Clin Ultrasound
Aim: To investigate the use of lung ultrasound (LUS) on COVID-19 patients, in emergency point of care settings, and to determine its diagnostic value compared with lung computed tomography (LCT) diagnostic performance.
DIAGNOSTICS
|
|
|
3/9/22
|
Kariyawasam RM, Julien DA, Jelinski DC, et al. | Antimicrob Resist Infect Control
Aim: To quantify the prevalence and types of resistant co-infecting organisms in patients with COVID-19 and explore differences across hospital and geographic settings. UPDATED
|
|
|
3/9/22
|
Wang Y, Li Y, Zhang Y, et al. | BMC Gastroenterol
Aim: To investigate the relationship between gastrointestinal symptoms and COVID-19 mortality.
CLINICAL CHARACTERISTICS
|
|
|
3/9/22
|
Alzoughool F, Abumweis S, Alanagreh L, et al. | Osong Public Health Res Perspect
Aim: To evaluate the association of pre-existing cardiovascular comorbidities, including hypertension and coronary heart disease, with coronavirus disease 2019 (COVID-19) severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
3/9/22
|
Balawender K, Pliszka A, Krowiak A, et al. | Curr Pharm Biotechnol
Aim: To present the current understanding of the effects of Covid-19 infection on the male genitourinary system.
CLINICAL CHARACTERISTICS
|
|
|
3/9/22
|
Sanghavi D, Bansal P, Kaur IP, et al. | Ann Med
Aim: To evaluate the role of colchicine on morbidity and mortality in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/9/22
|
Wafa IA, Pratama NR, Sofia NF, et al. | Diabetes Metab J
Aim: To investigate the differences in metabolic control parameters in diabetic patients before and during the lockdown. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/9/22
|
Beigi-Khoozani A, Merajikhah A, Soleimani M | Chin Med Sci J
Aim: To review the evidence on magnetic resonance imaging findings of olfactory bulb in anosmic patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/9/22
|
Soltani S, Zandi M, Faramarzi S, et al. | Osong Public Health Res Perspect
Aim: To determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
|
|
|
3/8/22
|
Martin-Martin J, Martin-Cazorla F, Suarez J, et al. | Curr Med Res Opin
Aim: To review complete autopsy cases and their postmortem findings and comorbidities associated with death caused by COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/8/22
|
Yao J, Zhang Y, Wang XZ, et al. | Front Public Health
Aim: To investigate the efficacy of flavonoids in treating viral ARTIs.
CANDIDATE THERAPEUTICS
|
|
|
3/8/22
|
Liao ZM, Zhang ZM, Liu Q | Ren Fail
Aim: To determine whether hydroxychloroquine/chloroquine increases the risk of acute kidney injury (AKI) in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/8/22
|
SeyedAlinaghi S, Karimi A, Barzegary A, et al. | Health Sci Rep
Aim: To review the evidence on mucormycosis co?infection in patients with COVID?19.
CLINICAL CHARACTERISTICS
|
|
|
3/7/22
|
Macedo ACL, Prestes GDS, Colonetti T, et al. | J Clin Virol
Aim: To evaluate the accuracy of serology for SARS-CoV-2 infections in cases confirmed or not by RT-PCR.
DIAGNOSTICS
|
|
|
3/7/22
|
Flumignan RL, Civile VT, Tinôco JDS, et al. | Cochrane Database Syst Rev
Aim: To assess the benefits and harms of anticoagulants versus active comparator, placebo or no intervention in people hospitalised with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/7/22
|
Aguiar de Sousa D, Romoli M, Sanchez Van Kammen M, et al. | Stroke
Aim: To systematically review the incidence, clinical features, and prognosis of CVT occurring in patients with HIT.
INFECTION CONTROL
|
|
|
3/7/22
|
Domingues RB, Leite FBVM, Senne C | Arq Neuropsiquiatr
Aim: To review the evidence on CSF findings relating to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/7/22
|
Chenchula S, Karunakaran P | J Med Virol
Aim: To review the evidence on the efficacy of the COVID-19 booster dose vaccination against the Omicron variant.
INFECTION CONTROL
|
|
|
3/7/22
|
Zhang J, Chen C, Yang Y, et al. | Medicine
Aim: To investigate the effectiveness of tocilizumab in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/7/22
|
Hu Y, Kung J, Cave A, et al. | J Pharm Pharm Sci
Aim: To determine the clinical effects of Vitamin D serum concentration in COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/7/22
|
Hessami K, Aagaard K, Castro EC, et al. | Am J Perinatol
Aim: To review the evidence on histopathologic findings in the placentas of women with SARS-CoV-2 infection during pregnancy.
CLINICAL CHARACTERISTICS
|
|
|
3/7/22
|
Yan Y, Du X, Lai L, et al. | J Geriatr Psychiatry Neurol
Aim: To estimate the prevalence of depressive and anxiety symptoms among older adults with different health conditions can inform mental health services for this population during the corona virus disease-2019 (COVID-19) pandemic. UPDATED
MENTAL HEALTH
|
|
|
3/7/22
|
Negrini F, de Sire A, Andrenelli E, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/4/22
|
Satpathy S, Wundaville LT, Satapathy S, et al. | J Patient Exp
Aim: To review the existing scales on patients’ satisfaction used for hospitalized patients and their application in COVID-19 situation.
CLINICAL CHARACTERISTICS
|
|
|
3/4/22
|
Izcovich A, Siemieniuk RA, Bartoszko JJ, et al. | BMJ Open
Aim: To summarise specific adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/4/22
|
Lee ARYB, Wong SY, Chai LYA, et al. | BMJ
Aim: To compare the efficacy of COVID-19 vaccines between immunocompromised and immunocompetent people. UPDATED
INFECTION CONTROL
|
|
|
3/4/22
|
Hu H, Pan H, Li R, et al. | Front Pharmacol
Aim: To identify the key factors associated to COVID-19 severity and death, especially in terms of the sex and race bias detected in severe COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
3/4/22
|
Krzych LJ, Putowski Z, Gruca K, et al. | Pol Arch Intern Med
Aim: To review the evidence on mortality in critically ill COVID-19 patients with fungal infections.
CLINICAL CHARACTERISTICS
|
|
|
3/4/22
|
Goyal M, Ray I, Mascarenhas D, et al. | QJM
Aim: To elucidate the clinical findings, laboratory parameters, treatment and outcomes of individuals with Myocarditis after COVID-19 vaccination. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/4/22
|
Collings AT, Jeyarajah DR, Hanna NM, et al. | Surg Endosc
Aim: To examine the existing evidence to provide guidance regarding MIS for the patient with, or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved.
INFECTION CONTROL
|
|
|
3/4/22
|
Chua PEY, Gwee SXW, Wang MX, et al. | Front Med
Aim: To compare the accuracy of different diagnostic tests (molecular, serology, clinical features, point of care testing, and imaging) and assess their potential utility as border screening for infection and immunity against SARS-CoV-2.
DIAGNOSTICS
|
|
|
3/4/22
|
TEA Clinical Profile of Infective Endocarditis in Patients with Recent COVID-19: A Systematic Review
Quintero-Martinez JA, Hindy JR, Mahmood M, et al. | Am J Med Sci
Aim: To provide a descriptive analysis of the clinical features and outcomes of patients with IE and recent COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Nguyen B, Tosti A | JAAD Int
Aim: To characterize the types, incidence, timing, and clinical outcomes of COVID-19-associated alopecia.
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Notarte KI, Guerrero-Arguero I, Velasco JV, et al. | J Med Virol
Aim: To characterize the kinetics of anti-SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) antibodies after the second dose of a primary cycle of COVID-19 mRNA vaccination. UPDATED
INFECTION CONTROL
|
|
|
3/2/22
|
Notarte KI, Ver AT, Velasco JV, et al. | Crit Rev Clin Lab Sci
Aim: To review the evidence on the possible effects of age, sex, serostatus, and comorbidities on humoral response (i.e. total antibodies, IgG, and/or IgA) of different populations post-mRNA-based Pfizer-BioNTech vaccination.
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Kang X, Jin D, Jiang L, et al. | Chin Med
Aim: To evaluate the efficacy and explore the mechanisms of TCM for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/2/22
|
Ben-Aicha S, Buchanan J, Punjabi P, et al. | Perfusion
Aim: To estimate the rate of in-hospital mortality following different treatments on COVID-19 in patients with CVD. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Damara FA, Muchamad GR, Anton, et al. | World Neurosurg
Aim: To evaluate the epidemiological characteristics of TBI patients before and during the COVID-19 pandemic. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
SeyedAlinaghi S, Karimi A, Mojdeganlou H, et al. | Health Sci Rep
Aim: To identify and summarize the impacts of the COVID?19 pandemic on routine vaccination coverage of children and adolescents.
INFECTION CONTROL
|
|
|
3/2/22
|
Ahmadieh A, Dincer S, Navazesh M | Oral Surg Oral Med Oral Pathol Oral Radiol
Aim: To assess the sensitivity rate of SARS-CoV-2 detection in the saliva of ambulatory asymptomatic and mildly symptomatic patients, with saliva being collected passively without any forceful coughing.
DIAGNOSTICS
|
|
|
3/2/22
|
Tayyebi H, Hasanikhah M, Heidarikhoo M, et al. | Curr Orthop Pract
Aim: To assess the in-hospital and 30-day mortality rates as well as the length of hospital stay in patients with COVID-19 infection who had hip fracture surgery.
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Kaka AS, MacDonald R, Linskens EJ, et al. | Ann Intern Med
Aim: To evaluate the effectiveness and harms of remdesivir for COVID-19. UPDATED VA ESP
CANDIDATE THERAPEUTICS
|
|
|
3/2/22
|
Mittal N, Mittal R, Gupta MC, et al. | Worldviews Evid Based Nurs
Aim: To systematically review the literature to answer the question: "What is the worldwide prevalence of mental health effects in children and adolescents during the COVID-19 pandemic?". UPDATED
MENTAL HEALTH
|
|
|
3/2/22
|
Lee ASY, Balakrishnan IDD, Khoo CY, et al. | Heart Lung Circ
Aim: To review the literature regarding myocarditis post COVID-19 vaccination, drawing from vaccine safety surveillance databases and case reports.
INFECTION CONTROL
|
|
|
3/2/22
|
Pashaei Z, SeyedAlinaghi S, Qaderi K, et al. | Health Sci Rep
Aim: The possible complications of COVID?19 infection in the fetus and newborn babies including the possibility and evidence of vertical transmission.
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Hannah JR, Ali SS, Nagra D, et al. | Clin Exp Rheumatol
Aim: To review the evidence on skeletal muscle involvement in COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/2/22
|
Pechlivanidou E, Vlachakis D, Tsarouhas K, et al. | Food Chem Toxicol
Aim: To summarize and describe human studies investigating the prognostic role of micronutrient status and the effects of micronutrient supplementation intervention in COVID-19 outcomes of adult patients.
CANDIDATE THERAPEUTICS
|
|
|
2/28/22
|
Yuniar CT, Pratiwi B, Ihsan AF, et al. | Vaccines
Aim: To summarize and critically evaluate the quality of harm reporting on randomized controlled trials for the COVID-19 vaccine and determine the factors associated with reporting quality.
INFECTION CONTROL
|
|
|
2/28/22
|
Pathirathna ML, Samarasekara BPP, Dasanayake TS, et al. | Healthcare
Aim: To evaluate the maternal, fetal and neonatal effects associated with COVID-19 in pregnancy. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Saeed H, Eslami A, Nassif NT, et al. | Int J Environ Res Public Health
Aim: To investigate the prevalence and associations of anxiety in different sample populations in relation to the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/28/22
|
Kim MS, Seong D, Li H, et al. | Rev Med Virol
Aim: To evaluate the comparative effectiveness of N95, surgical/medical and non-medical facemasks as personal protective equipment against respiratory virus infection.
INFECTION CONTROL
|
|
|
2/28/22
|
Jorda A, Kussmann M, Kolenchery N, et al. | Front Immunol
Aim: To evaluate whether the use of convalescent plasma is associated with improved clinical outcomes in patients with Covid-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/28/22
|
El-Qushayri AE, Kamel AMA, Reda A, et al. | Rev Med Virol
Aim: To give a summary of the available literature regarding the outcomes of dengue and COVID-19 co-infection.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Feikin DR, Higdon MM, Abu-Raddad LJ, et al. | Lancet
Aim: To systematically review the evidence for the duration of protection of COVID-19 vaccines against various clinical outcomes, and to assess changes in the rates of breakthrough infection caused by the delta variant with increasing time since vaccination.
INFECTION CONTROL
|
|
|
2/28/22
|
Szarpak L, Mierzejewska M, Jurek J, et al. | Biology
Aim: To determine the association between CAD and COVID-19 outcomes.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Ma Y, Deng J, Liu Q, et al. | Vaccines
Aim: To assess the effectiveness and safety of coronavirus disease 2019 (COVID-19) vaccines for pregnant women in real-world studies.
INFECTION CONTROL
|
|
|
2/28/22
|
Meggiolaro A, Sane Schepisi M, Nikolaidis GF, et al. | Vaccines
Aim: To assess the effectiveness of SARS-CoV-2 vaccines in terms of prevention of disease and transmission in the pre-Delta era.
INFECTION CONTROL
|
|
|
2/28/22
|
Fragkou PC, De Angelis G, Menchinelli G, et al. | Clin Microbiol Infect
Aim: To identify the most appropriate diagnostic test and/or diagnostic approach for SARS-CoV-2.
DIAGNOSTICS
|
|
|
2/28/22
|
Ahmadi Hekmatikar AH, Ferreira Júnior JB, Shahrbanian S, et al. | Int J Environ Res Public Health
Aim: To evaluate the effect of resistance or aerobic exercises in post-COVID-19 patients after hospital discharge.
CANDIDATE THERAPEUTICS
|
|
|
2/28/22
|
Oyelade T, Alqahtani JS, Hjazi AM, et al. | Trop Med Infect Dis
Aim: To assess the prevalence of people living with HIV (PLWH) among COVID-19 cases and whether HIV infection affects the risk of severe COVID-19 or related death at the global and continental level.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Kariyawasam JC, Jayarajah U, Abeysuriya V, et al. | Am J Trop Med Hyg
Aim: To outline the important liver manifestations of COVID-19 and discussed the possible underlying pathophysiological mechanisms and their diagnosis and management.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Han Q, Zheng B, Daines L, et al. | Pathogens
Aim: To systematically synthesise existing evidence on long-term post-COVID symptoms.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Tian Y, Lu H, Liu X, et al. | Medicine
Aim: To assess whether tricuspid annular plane systolic excursion (TAPSE) could be used as a prognostic tool in patients with coronavirus disease 19 (COVID-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Haseeb AA, Solyman O, Abushanab MM, et al. | Vaccines
Aim: To review the evidence on ocular complications following vaccination for COVID-19.
INFECTION CONTROL
|
|
|
2/28/22
|
Chen F, He Y, Shi Y | Vaccines
Aim: To estimate parents’ and guardians’ willingness to vaccinate their children against COVID-19 and identify the determinants of vaccination intention. UPDATED
INFECTION CONTROL
|
|
|
2/28/22
|
Chen Q, Li W, Xiong J, et al. | Int J Environ Res Public Health
Aim: To estimate the influence of the COVID-19 pandemic on the prevalence of PPD and to summarize and determine risk factors for PPD during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/28/22
|
Ng JW, Chong ETJ, Tan YA, et al. | Int J Environ Res Public Health
Aim: To provide insight into the prevalence of COVID-19 in 5 different clinical stages during the outset of the COVID-19 pandemic in Malaysia.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Tezcan B, Eraydin C, Karabacak BG | J Tissue Viability
Aim: To examine pressure ulcers in healthcare staff due to the use of protective equipment during COVID-19 pandemic and the precautions taken to prevent these injuries.
INFECTION CONTROL
|
|
|
2/28/22
|
Mendiola-Pastrana IR, López-Ortiz E, Río de la Loza-Zamora JG, et al. | Life
Aim: To analyze the impact of different SARS-CoV-2 variants on clinical outcomes.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Halim C, Mirza AF, Sari MI | Pathogens
Aim: To determine the relationship, if any, between TNF-alpha, IL-6, vitamin D, and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
|
|
|
2/28/22
|
Ferrara P, Gianfredi V, Tomaselli V, et al. | Vaccines
Aim: To summarize the real-world data from epidemiological studies investigating the impact of smoking and on the humoral response after COVID-19 vaccination.
INFECTION CONTROL
|
|
|
2/28/22
|
Lluch C, Galiana L, Doménech P, et al. | Healthcare
Aim: To determine the level of burnout, compassion fatigue, and compassion satisfaction, as well as their associated risks and protective factors, in healthcare professionals during the first year of the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/28/22
|
Esposito M, Salerno M, Di Nunno N, et al. | Healthcare
Aim: To analyze all possible prevention techniques to reduce the risk of COVID-19 related infection within prisons.
INFECTION CONTROL
|
|
|
2/28/22
|
Hashim NAF, Mahdy ZA, Abdul Rahman R, et al. | Front Public Health
Aim: To assess the justification for universal screening of pregnant women for COVID-19 prior to admission in labor through systematic review of antenatal prevalence of asymptomatic infection, hence risk of inadvertent spread of infection.
INFECTION CONTROL
|
|
|
2/28/22
|
Balboni E, Zagnoli F, Filippini T, et al. | J Trace Elem Med Biol
Aim: To review the evidence for possible effects of zinc or selenium on COVID-19, and therefore if there is any indication that increased intake of these trace elements is warranted and appropriate to prevent the current COVID-19 pandemic.
CANDIDATE THERAPEUTICS
|
|
|
2/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on budesonide and aspirin for pregnant women with COVID-19.
|
|
|
2/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/25/22
|
Pipitone G, Rindi LV, Petrosillo N, et al. | Infect Dis Rep
Aim: To review the evidence on vaccine-induced subacute thyroiditis (De Quervain's) after mRNA vaccine against SARS-CoV-2.
INFECTION CONTROL
|
|
|
2/24/22
|
An W, Wang Q, Kim TE, et al. | J Infect Public Health
Aim: To investigate the clinical characteristics, morbidity, severity, and mortality of COVID-19 infection among solid organ transplant (SOT) recipients by meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
2/24/22
|
Qaderi K, Golezar MH, Mardani A, et al. | Dermatol Ther
Aim: To summarize and integrated the findings of studies regarding cutaneous side effects of COVID-19 vaccines. UPDATED
INFECTION CONTROL
|
|
|
2/24/22
|
Abba-Aji M, Stuckler D, Galea S, et al. | J Migr Health
Aim: To review the evidence on ethnic minorities’ and migrants’ access to and acceptance of COVID-19 vaccines.
INFECTION CONTROL
|
|
|
2/24/22
|
Kunasekaran M, Quigley A, Rahman B, et al. | Open Forum Infect Dis
Aim: To explore the relationship of the physical layout of aged care facilities with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attack rates among residents.
INFECTION CONTROL
|
|
|
2/24/22
|
Li J, Wang Y, Liu Y, et al. | Eur J Med Res
Aim: To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/24/22
|
Isla A, Landy D, Teasdall R, et al. | Eur J Orthop Surg Traumatol
Aim: To explore the association of COVID-19 with short-term mortality in hip fracture patients.
CLINICAL CHARACTERISTICS
|
|
|
2/24/22
|
Hannemann J, Abdalrahman A, Erim Y, et al. | PLoS One
Aim: To summarize the evidence on the specific interplay of pandemic burden and psychosocial resources with regard to the mental health of HCWs during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/24/22
|
Chen Q, Zhu K, Liu X, et al. | Emerg Microbes Infect
Aim: To review the evidence on the efficacy and duration of protection provided by naturally acquired immunity against subsequent SARS-CoV-2 infection.
INFECTION CONTROL
|
|
|
2/24/22
|
Fabião J, Sassi B, Pedrollo EF, et al. | Braz J Med Biol Res
Aim: To study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/23/22
|
Jena A, James D, Singh AK, et al. | Clin Gastroenterol Hepatol
Aim: To systematically evaluate the seroconversion rates after complete COVID-19 vaccination in patients with inflammatory bowel disease (IBD).
INFECTION CONTROL
|
|
|
2/23/22
|
Wang Z, Zhao S, Tang Y, et al. | Eur J Pediatr
Aim: To evaluate the efficacy and safety of using potential drugs: remdesivir and glucocorticoid in treating children and adolescents with COVID-19 and intravenous immunoglobulin (IVIG) in treating MIS-C. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/22/22
|
Rottler M, Ocskay K, Sipos Z, et al. | Ann Intensive Care
Aim: To summarize the evidence on the efficacy of frailty tools in risk assessment in COVID-19 patients. UPDATED
|
|
|
2/22/22
|
Heidary M, Asadi A, Noorbakhsh N, et al. | J Clin Lab Anal
Aim: To discuss the characteristics of COVID-19 in HIV-positive patients.
CLINICAL CHARACTERISTICS
|
|
|
2/22/22
|
Kamat M, Datar U, Byakodi S, et al. | J Clin Transl Res
Aim: To report and analyze CAM regarding risk factors, clinical characteristics and to understand the associated pathogenesis.
CLINICAL CHARACTERISTICS
|
|
|
2/22/22
|
Marciano L, Ostroumova M, Schulz PJ, et al. | Front Public Health
Aim: To review the evidence on the link between mental health and digital media use in adolescents during Covid-19.
MENTAL HEALTH
|
|
|
2/22/22
|
Pandey SR, Adhikari Yadav S, Gautam S, et al. | F1000Res
Aim: To evaluate the clinical and radiological effects of LDRT in patients with severe acute respiratory syndrome (SARS) due to COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/22/22
|
Camacho-Montaño LR, Iranzo A, Martínez-Piédrola RM, et al. | Sleep Med Rev
Aim: To examine the evidence of the effects of coronavirus disease confinement on the sleep of children aged 12 years and younger.
|
|
|
2/22/22
|
| Pan American Health Organization
Aim: To review the evidence on the therapeutic options for COVID-19. UPDATED
|
|
|
2/22/22
|
Wang F, Wang D, Wang Y, et al. | Front Immunol
Aim: To identify the incidence rates of GBS that are temporally associated with viral vaccine administration but might not be attributable to the vaccines.
INFECTION CONTROL
|
|
|
2/22/22
|
Chu DK, Abrams EM, Golden DBK, et al. | JAMA Intern Med
Aim: To assess the risk of severe immediate allergic reactions (eg, anaphylaxis) to a second dose of SARS-CoV-2 mRNA vaccine among persons with immediate allergic reactions to their first vaccine dose.
INFECTION CONTROL
|
|
|
2/22/22
|
Galanis P, Vraka I, Siskou O, et al. | Prev Med
Aim: To estimate parents' willingness and refusal to vaccinate their children against the COVID-19, and to investigate the predictors for their decision. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/21/22
|
Zhang G, Kuang S, Zhang X | Hum Vaccin Immunother
Aim: To evaluate the reporting quality of COVID-19 vaccine randomized controlled trials (RCTs).
|
|
|
2/21/22
|
Elvidge J, Summerfield A, Nicholls D, et al. | Value Health
Aim: To review economic evaluations of diagnostic tests and treatments for COVID-19. UPDATED
|
|
|
2/21/22
|
Hossain AD, Jarolimova J, Elnaiem A, et al. | Lancet Public Health
Aim: To determine the effectiveness of contact tracing in the control of communicable illness.
INFECTION CONTROL
|
|
|
2/21/22
|
Ottisova L, Gillard JA, Wood M, et al. | J Trauma Stress
Aim: To summarize the evidence for the interventions in preventing or reducing adverse mental health outcomes in health care staff, with particular emphasis on PTSD, anxiety, depression, and sleep difficulties. UPDATED
MENTAL HEALTH
|
|
|
2/21/22
|
Yelin D, Moschopoulos CD, Margalit I, et al. | Clin Microbiol Infect
Aim: To provide evidence-based recommendations for assessment and management of individuals with persistent symptoms after acute COVID-19 infection, and provide a definition for this entity, termed “long COVID”.
CLINICAL CHARACTERISTICS
|
|
|
2/21/22
|
Silveira FM, Mello ALR, da Silva Fonseca L, et al. | Arch Oral Biol
Aim: To integrate the morphological and tissue-based molecular characterization of oral lesions occurring in individuals infected by COVID-19 (OLICs). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/21/22
|
Pardamean E, Roan W, Iskandar KTA, et al. | Gen Hosp Psychiatry
Aim: To analyze whether patients with pre-existing schizophrenia are at higher risk for Covid-19 mortality. UPDATED
MENTAL HEALTH
|
|
|
2/18/22
|
Yadav M, Singh A, Meena J, et al. | J Laryngol Otol
Aim: To review the evidence on the otorhinolaryngologic manifestations of COVID-19 in paediatric patients.
CLINICAL CHARACTERISTICS
|
|
|
2/18/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the COVID-19 pandemic and the wellbeing of critical care and other healthcare workers.
|
|
|
2/18/22
|
Caldeira D, Rodrigues BS, Alves M, et al. | Thromb J
Aim: To estimate the incidence of major bleeding events in this setting and to compare these risks against other vaccination routes.
INFECTION CONTROL
|
|
|
2/18/22
|
Du Z, Liu C, Wang C, et al. | Clin Infect Dis
Aim: To review the evidence on reproduction numbers of SARS-CoV-2 variants.
|
|
|
2/18/22
|
Kazemi S, Pourgholaminejad A, Saberi A | Basic Clin Neurosci
Aim: To review the change of stroke incidence during the COVID-19 pandemic period and the proposed mechanisms of the relationship between SARS-CoV-2 and stroke.
CLINICAL CHARACTERISTICS
|
|
|
2/18/22
|
Hannum ME, Koch RJ, Ramirez VA, et al. | Chem Senses
Aim: To establish the predicted prevalence rate of taste loss in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
2/18/22
|
Zhou JQ, Liu GX, Huang XL, et al. | J Med Virol
Aim: To review the evidence on the role of fecal nucleic acid detection of SARS-CoV-2 for quarantine and contact tracing.
DIAGNOSTICS
|
|
|
2/17/22
|
Di Felice G, Visci G, Teglia F, et al. | Elife
Aim: To compare the outcomes of unvaccinated COVID-19 patients with and without cancer.
CLINICAL CHARACTERISTICS
|
|
|
2/17/22
|
Xiao K, Gillissie ES, Lui LMW, et al. | J Affect Disord
Aim: To determine whether individuals with mental disorders exhibit differential immune response following the administration of vaccines for other infections.
|
|
|
2/17/22
|
Badenoch JB, Rengasamy ER, Watson C, et al. | Brain Commun
Aim: To determine the prevalence of neuropsychiatric symptoms in survivors of COVID-19. UPDATED
|
|
|
2/17/22
|
Nindrea RD, Djanas D, Warsiti, et al. | Clin Epidemiol Glob Health
Aim: To determine the risk factors and pregnant women's desire to get the SARS-CoV-2 vaccine in various countries.
INFECTION CONTROL
|
|
|
2/17/22
|
Harwood R, Yan H, Talawila Da Camara N, et al. | EClinicalMedicine
Aim: To identify which CYP were at increased risk of severe disease or death in CYP admitted to hospital with SARS-CoV-2 infection or PIMS-TS / MIS-C.
CLINICAL CHARACTERISTICS
|
|
|
2/16/22
|
Christensen RE, Jafferany M | JAAD Int
Aim: To investigate the association between new-onset alopecia areata or the exacerbation of pre-existing alopecia areata following infection with SARS-CoV-2.
CANDIDATE THERAPEUTICS
|
|
|
2/16/22
|
Schmidbauer ML, Ferse C, Salih F, et al. | J Clin Med
Aim: To systematically investigate incidence, mortality, radiological subtypes and clinical characteristics of ICH in COVID-19 patients. UPDATED
|
|
|
2/16/22
|
Barzegar M, Mirmosayyeb O, Ebrahimi N, et al. | Mult Scler Relat Disord
Aim: To assess the risk of coronavirus disease (COVID-19), clinical features and outcome among patients with neuromyelitis optica spectrum disorder (NMOSD).
CLINICAL CHARACTERISTICS
|
|
|
2/16/22
|
Shah K, Varna VP, Sharma U, et al. | QJM
Aim: To study the effect of vitamin D supplementation on morbidity and mortality in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
2/16/22
|
Veazie S, LaFavor B, Vela K, et al. | J Affect Disord Rep
Aim: To compare the prevalence of mental health disorders among adults who have been hospitalized for COVID-19 to relevant comparison groups, assess whether the prevalence of mental health disorders varies by patient and disease characteristics, and ascertain mental health care utilization and resource needs for adults following hospitalization for COVID-19. VA ESP
MENTAL HEALTH
|
|
|
2/16/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding post-acute and subacute care for COVID-19 patients. UPDATED
|
|
|
2/16/22
|
Slusarska B, Nowicki GJ, Niedorys-Karczmarczyk B, et al. | Int J Environ Res Public Health
Aim: To establish and estimate the combined incidence of depression and anxiety among nurses during the COVID-19 pandemic using standard measurement tools.
MENTAL HEALTH
|
|
|
2/16/22
|
Yeun YR, Kim SD | Int J Environ Res Public Health
Aim: To explore the psychological effects of online-based mindfulness programs during the COVID-19 pandemic.
|
|
|
2/16/22
|
Schiavetti I, Ponzano M, Signori A, et al. | Mult Scler Relat Disord
Aim: To estimate the mortality rate among patients under anti-CD-20 therapies.
MENTAL HEALTH
|
|
|
2/16/22
|
Rezaei S, Hoseinipalangi Z, Rafiei S, et al. | J Affect Disord Rep
Aim: To examine the prevalence of depression and the impact of various factors among hospital staff with a view to organize related programs for reducing the complications of these disorders. UPDATED
MENTAL HEALTH
|
|
|
2/15/22
|
Clark SE, Chisnall G, Vindrola-Padros C | EClinicalMedicine
Aim: To identify the supportive and operational strategies used for the flexible de-escalation of ICUs in the context of COVID-19. UPDATED
|
|
|
2/15/22
|
Elberry MH, Abdelgawad HAH, Hamdallah A, et al. | J Thromb Thrombolysis
Aim: To report susceptible demographics outcomes, commonalities, and prognosis of reporting cases.
CLINICAL CHARACTERISTICS
|
|
|
2/15/22
|
Tu J, Mo X, Zhang X, et al. | Expert Rev Respir Med
Aim: To assess the efficacy and safety of corticosteroids in COVID-19 patients compared with standard care or placebo. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/15/22
|
S?omka A, Kowalewski M, ?ekanowska E | Thromb Haemost
Aim: To assess the performance of TEG and TEM in the assessment of blood coagulation and fibrinolysis in patients with COVID-19.
|
|
|
2/15/22
|
Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, et al. | Blood Adv
Aim: To systematically review the clinical features and outcomes of patients with COVID-19 with confirmed HIT. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/15/22
|
Mehrabi Nejad MM, Moosaie F, Dehghanbanadaki H, et al. | Eur J Med Res
Aim: To evaluate the efficacy of COVID-19 mRNA vaccines in IC patients.
INFECTION CONTROL
|
|
|
2/15/22
|
| Stomatologija
Aim: To describe the clinical characteristics of oral lesions in patients with COVID-19.
INFECTION CONTROL
|
|
|
2/15/22
|
P2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: Effectiveness & adverse effects
 Kunstler B, Newton S, Hill H, et al. | Infect Dis Health
Aim: To examine the differences in likelihood of SARS-CoV-2 infection and AEs between HCWs using respirators and surgical masks.
INFECTION CONTROL
|
|
|
2/15/22
|
Norhayati MN, Che Yusof R, Azman YM | Front Med
Aim: To estimate the pooled proportion of COVID-19 vaccine acceptance worldwide. UPDATED
INFECTION CONTROL
|
|
|
2/15/22
|
Zhang X, Shang L, Fan G, et al. | Front Med
Aim: To provide a comprehensive summary of current evidence for a better understanding of the efficacy and safety of JAK inhibitors for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
2/14/22
|
Nguyen NN, Hoang VT, Dao TL, et al. | Eur J Clin Microbiol Infect Dis
Aim: To describe the burden of the long-term persistence of clinical symptoms in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
2/14/22
|
Yang P, Wang J, Zheng R, et al. | Heart Lung
Aim: To evaluate the clinical improvement and mortality risk of convalescent plasma treatment in patients with severe and critically ill COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
2/14/22
|
Xiao D, Tang F, Chen L, et al. | Front Cardiovasc Med
Aim: To evaluate the association between thrombosis and the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
2/14/22
|
Kariyawasam RM, Dingle TC, Kula BE, et al. | Clin Microbiol Infect
Aim: To review the prevalence, diagnosis, treatment, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) and compare research definitions.
CLINICAL CHARACTERISTICS
|
|
|
2/14/22
|
Koritala T, Pattan V, Tirupathi R, et al. | Infez Med
Aim: To summarize infection risk of IL inhibitors, with or without the use of corticosteroids, used to treat hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
2/14/22
|
Ao G, Li J, Yuan Y, et al. | Nutr Clin Pract
Aim: To compare the disease severity and mortality in patients with COVID-19 who promptly received IV-VC treatment vs those who did not.
CANDIDATE THERAPEUTICS
|
|
|
2/14/22
|
Bachour Y, Bekkenk MW, Rustemeyer T, et al. | J Cosmet Dermatol
Aim: To review the evidence on late inflammatory reactions in patients with soft tissue fillers after infection with SARS-CoV-2 and vaccination.
CLINICAL CHARACTERISTICS
|
|
|
2/14/22
|
Nagalli S, Kikkeri NS | Infez Med
Aim: To study the patient’s characteristics, risk factors, complications, and outcomes of COVID-19 patients diagnosed with mucormycosis.
CLINICAL CHARACTERISTICS
|
|
|
2/14/22
|
Alali AH, Smaisem MS, Alsheikh AM, et al. | Infez Med
Aim: To explore myocardial injury in coronavirus disease-19 (COVID-19) patients who were hospitalized with severe complicated infections.
CLINICAL CHARACTERISTICS
|
|
|
2/14/22
|
Dilokthornsakul W, Kosiyaporn R, Wuttipongwaragon R, et al. | J Integr Med
Aim: To review the mechanisms of propolis and honey against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and current evidence for the use of propolis and honey in COVID-19 prevention and treatment.
CANDIDATE THERAPEUTICS
|
|
|
2/14/22
|
Hosen I, Al-Mamun F, Mamun MA | Glob Ment Health
Aim: To review the Bangladeshi literature related to common mental health problems (i.e. depression, anxiety, and stress) during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/14/22
|
Zarghami A, Hussain MA, Campbell JA, et al. | Mult Scler Relat Disord
Aim: To conduct a rapid systematic review of the existing evidence on impact of the COVID-19 pandemic on mental health outcomes among PwMS.
MENTAL HEALTH
|
|
|
2/11/22
|
Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, et al. | Rev Neurosci
Aim: To describe the prevalence and risk of ACVE in patients with severe and nonsevere COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/11/22
|
Pischel L, Patel KM, Goshua G, et al. | Clin Infect Dis
Aim: To explore the potential associations of adenovirus-based vaccine components with symptoms of TTS in the general clinical trial population and in pregnant women in clinical trials.
INFECTION CONTROL
|
|
|
2/11/22
|
da Silva CGL, Santana JRP, Pinheiro LFG, et al. | Adv Exp Med Biol
Aim: To analyze the main morphofunctional changes in the involvement of multiple organs in patients infected with SARS-CoV-2, correlating anatomopathological findings with the clinical picture.
CLINICAL CHARACTERISTICS
|
|
|
2/11/22
|
Ramandi A, Akbarzadeh MA, Khaheshi I, et al. | Curr Probl Cardiol
Aim: To review articles inclusive of aortic dissection concurrent with Covid-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
2/11/22
|
Jaiswal V, Nepal G, Dijamco P, et al. | J Prim Care Community Health
Aim: To systematically review the baseline features, clinical characteristics, treatment, and outcomes in patients developing CVST post-COVID-19 vaccination.
CLINICAL CHARACTERISTICS
|
|
|
2/11/22
|
Sharif PM, Nematizadeh M, Saghazadeh M, et al. | Pol J Radiol
Aim: To summarize the available data regarding chest CT features in confirmed cases of COVID-19.
DIAGNOSTICS
|
|
|
2/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/11/22
|
Dettmann LM, Adams S, Taylor G | Br J Clin Psychol
Aim: To determine the prevalence of anxiety and depression during the first UK COVID-19 lockdown. UPDATED
MENTAL HEALTH
|
|
|
2/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/11/22
|
Jahn R, Hintermeier M, Bozorgmehr K | J Migr Health
Aim: To quantify the attack rate of SARS-CoV-2 during outbreaks among refugees living in reception and accommodation centres in Germany.
INFECTION CONTROL
|
|
|
2/11/22
|
Avallone G, Quaglino P, Cavallo F, et al. | Int J Dermatol
Aim: To provide an extensive overview of all the vaccine-related cutaneous manifestations reported in the literature thus far.
INFECTION CONTROL
|
|
|
2/11/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
2/11/22
|
Liu N, Yang D, Zhang T, et al. | Int J Infect Dis
Aim: To assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/11/22
|
Hsu CK, Chen CY, Chen WC, et al. | Int J Antimicrob Agents
Aim: To assess the impact of sofosbuvir-based treatment on the mortality of patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
2/11/22
|
Al Kiyumi MH, Kalra S, Davies JS, Kalhan A | Indian J Endocrinol Metab
Aim: To ascertain the prevalence of VDD in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/11/22
|
Ji Y, Fang Y, Cheng B, et al. | Crit Care
Aim: To systematically appraise the existing COVID-19 studies examining the impact of ET on the primary outcomes of duration of IMV, duration of ICU stay, and overall reported mortality and secondary outcomes of ventilator-associated pneumonia (VAP), time from tracheostomy to ventilator weaning, and duration of sedation.
CANDIDATE THERAPEUTICS
|
|
|
2/11/22
|
Tanni SE, Silvinato A, Floriano I, et al. | J Bras Pneumol
Aim: To answer questions related to the use of remdesivir for the treatment of patients hospitalized with moderate to severe COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
2/9/22
|
Audrey J, Wisnu W, Tahapary DL | Curr Diabetes Rev
Aim: To investigate the association between statin use and poor outcomes in COVID-19 patients with diabetes.
CLINICAL CHARACTERISTICS
|
|
|
2/9/22
|
Bhatt A, Bumbrah GS, Ruwali M, et al. | Pathog Glob Health
Aim: To assess the diagnostic efficiency of RT-LAMP integrated CRISPR-Cas technology.
DIAGNOSTICS
|
|
|
2/9/22
|
Cuninghame S, Gorsky K, Francoeur C, et al. | BMJ Open
Aim: To summarise the known effects of inhaled sedatives on cognitive and psychiatric outcomes.
|
|
|
2/9/22
|
Han S, Zhuang Q, Chiang J, et al. | BMJ Open
Aim: To determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA).
CLINICAL CHARACTERISTICS
|
|
|
2/9/22
|
Al-Maiahy TJ, Al-Kuraishy HM, Al-Gareeb AI | J Pak Med Assoc
Aim: To illustrate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during pregnancy and to explore pregnancy outcomes, vertical and perinatal transmission as well as management of coronavirus disease-2019 (Covid-19) during pregnancy.
CLINICAL CHARACTERISTICS
|
|
|
2/9/22
|
Brown C, Wilkins K, Craig-Neil A, et al. | Public Health Rev
Aim: To identify the areas of greatest concern and synthesize recommendations to support a more equitable pandemic response.
|
|
|
2/9/22
|
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis | J Korean Med Sci
Aim: To identify children at high risk of severe COVID-19, with a focus on comorbidities and age.
CLINICAL CHARACTERISTICS
|
|
|
2/9/22
|
Jahrami HA, Alhaj OA, Humood AM, et al. | Sleep Med Rev
Aim: To evaluate the extent of sleep disturbances during the COVID-19 pandemic. UPDATED
|
|
|
2/9/22
|
Boppana TK, Mittal S, Madan K, et al. | Monaldi Arch Chest Dis
Aim: To estimate the effectiveness of tocilizumab in reduction of mortality due to COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
2/8/22
|
Mendoza JPIM, Ubillús BPT, Bolívar GTS, et al. | Saudi Dent J
Aim: To evaluate the antiviral effect of mouthwashes against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). UPDATED
|
|
|
2/8/22
|
Abas?yan?k Z, Kurt M, Kahraman T | J Dev Phys Disabil
Aim: To investigate the physical activity changes in people with neurological diseases, and to examine the relationship between physical activity and disease symptoms, and psychosocial factors. UPDATED
|
|
|
2/8/22
|
Carrara E, Ong DSY, Hussein K, et al. | Clin Microbiol Infect
Aim: To address the indications for direct testing of SARS-CoV-2 in asymptomatic individuals in healthcare facilities with the aim to prevent SARS-CoV-2 transmissions in these settings.
INFECTION CONTROL
|
|
|
2/8/22
|
Shi S, Wang F, Yao H, et al. | Front Med
Aim: To evaluate the potential effect of CHM on immune related profile compared with routine treatment during COVID-19, and to investigate whether the clinical parameters were improved through the immunity profile based on randomized controlled trials (RCTs). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/8/22
|
Alkodaymi MS, Omrani OA, Fawzy NA, et al. | Clin Microbiol Infect
Aim: To estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods.
CLINICAL CHARACTERISTICS
|
|
|
2/8/22
|
Budi DS, Pratama NR, Wafa IA, et al. | Heliyon
Aim: To critically evaluate and summarize the latest evidence of remdesivir for COVID-19 in terms of its efficacy and safety profile among pregnant women. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/8/22
|
Sakuraba A, Luna A, Micic D | J Hematol Oncol
Aim: To assess the serologic response to COVID-19 vaccination in patients with cancer.
INFECTION CONTROL
|
|
|
2/8/22
|
Wang Y, Zhu K, Dai R, et al. | Front Pharmacol
Aim: To evaluate the efficacy and safety of specific interleukin (IL)-1 inhibitors, specific IL-6 inhibitors, and GM-CSF blockades in the treatment of COVID-19 (at the edge of sepsis) patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/8/22
|
Soysal P, Smith L, Trott M, et al. | Psychogeriatrics
Aim: To investigate the effects of the COVID-19 lockdown on neuropsychiatric symptoms (NPS) in people living with dementia/MCI.
MENTAL HEALTH
|
|
|
2/8/22
|
Baker J, Krishnan N, Abroms LC, et al. | J Smok Cessat
Aim: To determine whether a history of tobacco use increases risks for adverse outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
2/8/22
|
Tan Z, Huang S, Mei K, et al. | Front Cardiovasc Med
Aim: To determine the prevalence and associated death of ventricular arrhythmia and sudden cardiac death (SCD) in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/7/22
|
Ganesh A, Randall MD | Br J Clin Pharmacol
Aim: To investigate the effects of metformin on outcomes in patients with COVID-19 and DM. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
2/7/22
|
Wu H, Dai R, Wu X, et al. | Am J Chin Med
Aim: To evaluate the efficacy and safety of traditional Chinese medicine for COVID-19 treatment with a focus on the benefits of symptomatic relief and time-related indexes.
CANDIDATE THERAPEUTICS
|
|
|
2/7/22
|
Schietzel S, Anderegg M, Limacher A, et al. | RMD Open
Aim: To review the evidence on SARS-CoV-2 vaccine induced humoral and cell-mediated immune response in patients previously treated with anti-CD20 antibodies.
INFECTION CONTROL
|
|
|
2/7/22
|
Premraj L, Kannapadi NV, Briggs J, et al. | J Neruol Sci
Aim: To determine the prevalence of neurological and neuropsychiatric symptoms reported 12 weeks (3 months) or more after acute COVID-19 onset in adults.
CLINICAL CHARACTERISTICS
|
|
|
2/7/22
|
Safi-Keykaleh M, Aliakbari F, Safarpour H, et al. | Int J Gynaecol Obstet
Aim: To evaluate the prevalence of postpartum depression during COVID-19. UPDATED
MENTAL HEALTH
|
|
|
2/7/22
|
Zhang H, Xie F, Yang B, et al. | Am J Infect Control
Aim: To explore the experience of COVID-19 patients. UPDATED
MENTAL HEALTH
|
|
|
2/7/22
|
Duarsa MDVI, Kandarini Y, Yogiswara N, et al. | Truk J Urol
Aim: To systematically review the current findings regarding survival and clinical outcomes of KT recipients with COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
2/7/22
|
Aldukhayel A | Endokrynol Pol
Aim: To synthesize evidence on the impact of the COVID-19 lockdown on the glycaemic control, physical activity, and diet of diabetic patients.
|
|
|
2/7/22
|
Mohammed I, Nauman A, Paul P, et al. | Hum Vaccin Immunother
Aim: To compare the efficacy and effectiveness of seven COVID-19 vaccines.
INFECTION CONTROL
|
|
|
2/7/22
|
Petrelli F, Luciani A, Borgonovo K, et al. | J Med Virol
Aim: To review the evidence on the efficacy and safety of a third dose of COVID-19 vaccine in various general population settings.
INFECTION CONTROL
|
|
|
2/7/22
|
Shi N, Huang J, Ai J, et al. | J Infect Public Health
Aim: To review the evidence on the transmissibility and pathogenicity of COVID-19.
INFECTION CONTROL
|
|
|
2/4/22
|
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize their clinical features, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
2/4/22
|
Chu CW, Jiesisibieke ZL, Yang YP, et al. | Expert Rev Vaccines
Aim: To review the evidence on the association between herpes zoster and COVID-19 vaccinations.
INFECTION CONTROL
|
|
|
2/4/22
|
Malik J, Zaidi SMJ, Waqar AU, et al. | Expert Rev Endocrinol Metab
Aim: To assess the prevalence of hypothyroidism in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
2/4/22
|
Chutiyami M, Cheong AMY, Salihu D, et al. | Front Psychiatry
Aim: To provide a comprehensive overview of overall mental health of healthcare professionals during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/4/22
|
Ergün A, Bekar A, Aras B, et al. | Turk Thorac J
Aim: To survey how vaccine hesitancy is addressed in the PubMed articles about "vaccine hesitancy" over the novel coronavirus disease and to understand their recommendations for the prevention of vaccine hesitancy.
INFECTION CONTROL
|
|
|
2/4/22
|
Patoulias D, Doumas M | Endocrinol Metab
Aim: To review the evidence from observational studies addressing the risk of COVID-19 death among patients with type 2 diabetes mellitus on prior DPP-4 inhibitor treatment.
CANDIDATE THERAPEUTICS
|
|
|
2/4/22
|
Mir T, Attique HB, Sattar Y, et al. | Cardiovasc Revasc Med
Aim: To evaluate the mortality outcomes of critically ill patients with and without PE (WPE).
CLINICAL CHARACTERISTICS
|
|
|
2/4/22
|
Rincón Uribe FA, Godinho RCS, Machado MAS, et al. | PLoS One
Aim: To offer a rapid synthesis of the evidence about effect of health knowledge, as broader measure that includes detailed and objective information on health components, to adopt health behaviors and attitudes during pandemics.
INFECTION CONTROL
|
|
|
2/4/22
|
Rivera PA, Nys BL, Fiestas F | Medwave
Aim: To investigate the impact of COVID-19-induced lockdowns on university student physical activity and sedentary behav-ior, as these relate to physical and mental well-being.
MENTAL HEALTH
|
|
|
2/4/22
|
Pratama NR, Wafa IA, Budi DS, et al. | PLoS One
Aim: To review the latest evidence on Covid-19 vaccination to summarize its efficacy, immunogenicity, and safety profile in pregnant women.
INFECTION CONTROL
|
|
|
2/4/22
|
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate the pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS).
CLINICAL CHARACTERISTICS
|
|
|
2/4/22
|
Ouyang L, Gong J, Yu M | Int Immunopharmacol
Aim: To investigate the prevalence of ILD among patients with COVID-19 and figure out the relationship between ILD and the poor clinical outcomes of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
2/4/22
|
Norhayati MN, Che Yusof R, Azman MY | Int J Environ Res Public Health
Aim: To ascertain the prevalence of psychological impacts among healthcare providers in the Asian region. UPDATED
MENTAL HEALTH
|
|
|
2/4/22
|
Prada L, D Santos C, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs.
CLINICAL CHARACTERISTICS
|
|
|
2/4/22
|
Montero-Vilchez T, Cuenca-Barrales C, Martinez-Lopez A, et al. | J Eur Acad Dermatol Venereol
Aim: To summarize the prevalence, type and risk factors for cutaneous adverse events related to PPE and prevention measures to avoid them.
INFECTION CONTROL
|
|
|
2/4/22
|
Schmidt RA, Genois R, Jin J, et al. | Drug Alcohol Depend
Aim: To examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems. UPDATED
MENTAL HEALTH
|
|
|
2/4/22
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of transmission of COVID-19 within post-secondary institutions and the strategies to mitigate on-campus outbreaks? UPDATED
|
|
|
2/3/22
|
Soetedjo NNM, Iryaningrum MR, Lawrensia S, et al. | Diabetes Metab Syndr
Aim: To explore the SARS-CoV-2 antibody response or seropositivity among DM patients following the COVID-19 vaccine administration.
INFECTION CONTROL
|
|
|
2/3/22
|
Bareeqa SB, Samar SS, Javed G, et al. | Curr Treat Options Psychiatry
Aim: To identify the media-reported cases of COVID-related suicides.
MENTAL HEALTH
|
|
|
2/3/22
|
Li H, Yuan K, Sun YK, et al. | Transl Psychiatry
Aim: To explore (1) the efficacy of facemask use on preventing respiratory infections, and (2) the perceptions, intentions, and practice about facemask use among the general population worldwide.
INFECTION CONTROL
|
|
|
2/2/22
|
Vegivinti CTR, Evanson KW, Lyons H, et al. | BMC Infect Dis
Aim: To review current evidence obtained from randomized clinical trials on the efficacy of antivirals for COVID-19 treatment.
CANDIDATE THERAPEUTICS
|
|
|
2/2/22
|
Marconcin P, Werneck AO, Peralta M, et al. | BMC Public Health
Aim: To examine the association between physical activity and mental health during the first year of the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
2/2/22
|
Chivese T, Matizanadzo JT, Musa OAH, et al. | Pathog Glob Health
Aim: To estimate the prevalence and longevity of detectable SARS-CoV-2 antibodies and T and B memory cells after recovery.
INFECTION CONTROL
|
|
|
2/2/22
|
Sharma A, D Goel A, Bhardwaj P, et al. | Anaesthesiol Intensive Ther
Aim: To review the outcomes of coronavirus disease 2019 (COVID-19) patients who underwent tracheostomy.
CLINICAL CHARACTERISTICS
|
|
|
2/2/22
|
| COVID-END
Aim: To review the evidence on the efficacy and effectiveness of available COVID-19 vaccines for variants of concern. UPDATED
|
|
|
2/1/22
|
Pogorelic Z, Anand S, Artukovic L, et al. | J Pediatr Urol
Aim: To evaluate whether the Coronavirus Disease 2019 (COVID-19) pandemic resulted in a prolonged duration of symptoms, a delayed presentation to the medical facility, and consequently more orchiectomy procedures among children with testicular torsion compared to the pre-COVID-19 period.
|
|
|
2/1/22
|
De Hert M, Mazereel V, Stroobants M, et al. | Front Psychiatry
Aim: To assess the risk of death associated with COVID-19 infection in people with SMI (schizophrenia spectrum disorders, BD, and MDD), compared with patients without SMI, or without any psychiatric disorder.
CLINICAL CHARACTERISTICS
|
|
|
2/1/22
|
Tian Y, Wu Q, Li H, et al. | Can Respir J
Aim: To review the evidence on the clinical characteristics of COVID-19 in patients based on geographical regions. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
2/1/22
|
Mohammed SA, Eid KM, Anyiam FE, et al. | Egypt Liver J
Aim: To confirm the correlation of liver involvement in SARS-CoV-2 infection patients and detect the prognosis relationship with COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
2/1/22
|
Ippolito S, Gallo D, Rossini A, et al. | J Endocrinol Invest
Aim: To perform a systematic review on published cases of subacute thyroiditis (SAT) secondary to SARS-CoV-2 vaccination, to highlight main features and increase the awareness of this condition.
INFECTION CONTROL
|
|
|
2/1/22
|
Chivese T, Matizanadzo M, Musa O, et al. | Pathog Glob Health
Aim: To estimate the prevalence and longevity of detectable SARS-CoV-2 antibodies and T and B memory cells after recovery. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/31/22
|
Abbas AS, Hardy N, Ghozy S, et al. | Clin Neurol Neursurg
Aim: To assess the outcomes of invasive ventilation, mortality, and hospital length of stay (HLoS) for patients presenting with MG and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/31/22
|
Yang J, D'Souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To review the evidence on pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/31/22
|
Varikasuvu SR, Thangappazham B, Vykunta A, et al. | Expert Rev Anti Infect Ther
Aim: To evaluate the use of vitamin D intervention on COVID-19 outcomes. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/31/22
|
Masoudi M, Maasoumi R, Bragazzi NL | BMC Public Health
Aim: To systematically identify, collect and summarize the existing body of evidence from published studies on the effects of COVID-19 pandemic on sexual activity and functioning.
MENTAL HEALTH
|
|
|
1/31/22
|
Phillips K, Knowlton M, Riseden J | Adv Emerg Nurs J
Aim: To explore the actions that can be taken by management to combat burnout by ED nurses.
MENTAL HEALTH
|
|
|
1/31/22
|
Pepera G, Tribali MS, Batalik L, et al. | Rev Cardiovasc Med
Aim: To assess the link between COVID-19 and cardiovascular risk factors, and investigate the prognosis in the case of myocardial injury. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/31/22
|
Haase KR, Verma R, Kilgour HM | Curr Opin Support Palliat Care
Aim: To summarize the literature on the impact of COVID-19 on older adults with cancer, including both the impacts of COVID-19 diagnosis on older adults with cancer and the implications of the pandemic on cancer care.
CLINICAL CHARACTERISTICS
|
|
|
1/31/22
|
Lin WT, Hung SH, Lai CC, et al. | J Med Virol
Aim: To assess the clinical efficacy and safety of neutralizing monoclonal antibodies (mABs) for outpatients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/31/22
|
Jia L, Huffman WH, Cusano A, et al. | Phys Sportsmed
Aim: To evaluate COVID-19 transmission rates in athletes upon return to sport (RTS), as well as the effectiveness of preventive and surveillance measures associated with RTS.
INFECTION CONTROL
|
|
|
1/31/22
|
Adham M, Anam K, Reksodiputro L | Med J Malaysia
Aim: To review and discuss existing research on treatment prioritization and risk stratification of head and neck cancer patients during the pandemic.
|
|
|
1/28/22
|
| CADTH
Aim: To provide a summary of resources and literature about the outcomes and impacts of COVID-19 on Indigenous populations in Canada.
|
|
|
1/28/22
|
Lim PC, Wong KL, Rajah R, et al. | Daru
Aim: To collate studies investigating the use of tocilizumab and corticosteroids particularly dexamethasone and methylprednisolone in COVID-19 treatment and sought for summative evidence for their efficacy in treating the disease.
CANDIDATE THERAPEUTICS
|
|
|
1/28/22
|
Dar-Odeh N, Bobamuratova DT, Alnazzawi A, et al. | Cranio
Aim: To highlight jaw-related complications in COVID-19 manifestations, their etiology, and prevention methods.
CLINICAL CHARACTERISTICS
|
|
|
1/28/22
|
Singh R, Rathore SS, Khan H, et al. | Front Med
Aim: To investigate the association of ACEIs and ARBs used in COVID-19 and its effect on the mortality rate and severity of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/28/22
|
Bepouka B, Situakibanza H, Sangare M, et al. | J Clin Hypertens
Aim: To evaluate the magnitude of COVID-19 mortality in patients with hypertension in SSA.
CLINICAL CHARACTERISTICS
|
|
|
1/28/22
|
Sanchez-Garcia M, Rodriguez-Del Rey T, Perez-Saez E, et al. | Rev Neurol
Aim: To know the impact of lockdown measures imposed due to the COVID-19 pandemic on neuropsychiatric symptomatology in people with mild cognitive impairment and dementia.
MENTAL HEALTH
|
|
|
1/28/22
|
Demeke J, McFadden SM, Dada D, et al. | J Community Health
Aim: To review the evidence on the effectiveness of intervention strategies to increase COVID-19 vaccine uptake among documented and undocumented immigrants.
INFECTION CONTROL
|
|
|
1/27/22
|
Zein AFMZ, Raffaello WM | Diabetes Metab Syndr
Aim: To evaluate the latest evidence on the association between colchicine and mortality in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
1/27/22
|
Díaz LA, García-Salum T, Fuentes-López E, et al. | Gastroenterol Hepatol
Aim: To assess the clearance time in stools of SARS-CoV-2. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/27/22
|
Kharel M, Sakamoto JL, Carandang RR, et al. | BMJ Glob Health
Aim: To examine the impact of COVID-19 lockdown on children and adolescents' movement behaviours. UPDATED
|
|
|
1/27/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on cases of COVID-19 on the pediatric population in Australia.
|
|
|
1/27/22
|
Boppana TK, Mittal S, Madan K, et al. | Monaldi Arch Chest Dis
Aim: To estimate the effectiveness of steroid administration in mortality reduction due to COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
1/27/22
|
Gil-Rodríguez J, Pérez de Rojas J, Aranda-Laserna P, et al. | Eur J Radiol
Aim: To identify the defining LUS findings of COVID-19, and to establish its association to the initial severity of the disease and prognostic outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/26/22
|
| IRIS PAHO
Aim: To review the evidence on potential therapeutic options for COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/26/22
|
Helfand M, Fiordalisi C, Wiedrick J, et al. | Ann Intern Med
Aim: To synthesize evidence on protection against reinfection after SARS-CoV-2 infection.
INFECTION CONTROL
|
|
|
1/25/22
|
Gupta P, Gupta M, KAtoch N, et al. | Int J Endocrinol Metab
Aim: To determine the overall mortality and diabetes-associated mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
1/25/22
|
Deb P, Zannat KE, Talukder S, et al. | HLA
Aim: To identify significant HLAs for their association with COVID 19.
CLINICAL CHARACTERISTICS
|
|
|
1/25/22
|
Thakur B, Pathak M | Indian J Community Med
Aim: To assess the burden of mental health outcomes predominantly on the prevalence of anxiety, depression, stress, and insomnia during COVID-19 global emergency among three group of the population, i.e. frontline health-care workers (FHW), nonFHWs (NFHW) and the general population who are not healthcare workers. UPDATED
MENTAL HEALTH
|
|
|
1/25/22
|
Khera D, Chugh A, Khasbage S, et al. | Indian J Community Med
Aim: To review the evidence on whether BCG vaccination provides protection against COVID-19.
INFECTION CONTROL
|
|
|
1/25/22
|
Sathian B, Banerjee I, Mekkodathil AA, et al. | Nepal J Epidemiol
Aim: To review the evidence on the epidemiologic and clinical characteristics of COVID-19 in pregnant women.
CLINICAL CHARACTERISTICS
|
|
|
1/25/22
|
Subramaniam A, Shekar K, Afroz A, et al. | Intern Med J
Aim: To examine associations between frailty and short-term mortality in patients hospitalised with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/25/22
|
Esmaeili M, Abdi F, Shafiee G, et al. | Int J Prev Med
Aim: To systematically review and pool all available evidence on the olfactory and gustatory dysfunction in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/25/22
|
Fleischmann E, Dalkner N, Fellendorf FT, et al. | World J Psychiatry
Aim: To assess the situation of patients with serious mental illness (SMI: Affective disorders and schizophrenia) regarding their mental health outcome during the pandemic.
MENTAL HEALTH
|
|
|
1/25/22
|
Lugli G, Ottaviani MM, Botta A, et al. | Mediterr J Hematol Infect Dis
Aim: To investigate the management of non-COVID-19 patients across all medical specialities in Italy.
INFECTION CONTROL
|
|
|
1/24/22
|
Zhang SX, Chen RZ, Xu W, et al. | Int J Environ Res Public Health
Aim: To calculate the prevalence of anxiety, depression, and insomnia symptoms in Spain's adult population (general population, frontline healthcare workers (HCWs), and adult students) during the Covid-19 epidemic.
MENTAL HEALTH
|
|
|
1/24/22
|
Singh AK, Singh A, Singh R, et al. | Diabetes Metab Syndr
Aim: To conduct an update on our previous systematic review to provide practical clinical guideline for using molnupiravir in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
1/24/22
|
Schmid B, Griesel M, Fischer AL, et al. | J Clin Med
Aim: To analyze the available evidence on HFNC vs. NIV and APP vs. standard of care (SoC) on COVID-19-associated respiratory failure. UPDATED
|
|
|
1/24/22
|
Mohanty RR, Das S, Padhy BM, et al. | J Assoc Physicians India
Aim: To address whether choice of systemic corticosteroid significantly influences the clinical outcome of COVID 19 patients.
CANDIDATE THERAPEUTICS
|
|
|
1/24/22
|
Aymerich C, Pedruzo B, Pérez JL, et al. | Eur Psychiatry
Aim: To synthesise the available scientific evidence about the state of mental health of HCWs during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
1/24/22
|
Pormohammad A, Zarei M, Ghorbani S, et al. | Vaccines
Aim: To address the knowledge gap of vaccine effectiveness (VE) towards the SARS-CoV-2 Delta variant.
INFECTION CONTROL
|
|
|
1/24/22
|
Vahedian-Azimi A, Abbasifard M, Rahimi-Bashar F, et al. | Nutrients
Aim: To investigate the efficacy of supplemental curcumin treatment on clinical outcomes and inflammation-related biomarker profiles in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
1/24/22
|
Lee ARYB, Wong SY, Chai LYA, et al. | BMJ
Aim: To compare the efficacy of covid-19 vaccines between immunocompromised and immunocompetent people.
INFECTION CONTROL
|
|
|
1/24/22
|
Focosi D, Franchini M, Tuccori M, et al. | Vaccines
Aim: To evaluate the efficacy and safety of polyclonal intravenous immunoglobulin (IVIG) therapy in COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/24/22
|
Shakeel CS, Mujeeb AA, Mirza MS, et al. | Vaccines
Aim: To examine how and why the rates of COVID-19 vaccine acceptance and hesitancy differ across countries and continents.
INFECTION CONTROL
|
|
|
1/24/22
|
Pogorelic Z, Anand S, Zuvela T, et al. | Diagnostics
Aim: To evaluate whether the COVID-19 pandemic resulted in higher incidence of complicated appendicitis in children presenting with acute appendicitis compared to the pre-COVID-19 period.
|
|
|
1/24/22
|
Wu HHL, Shenoy M, Kalra PA, et al. | Children
Aim: To delineate the range of intrinsic kidney pathologies that have manifested following acute COVID-19 infection in children.
CLINICAL CHARACTERISTICS
|
|
|
1/24/22
|
Bshesh K, Khan W, Vattoth AL, et al. | J Med Virol
Aim: To review the evidence on events of lymphadenopathy reported post-COVID-19 vaccination and the recommendations to avoid any clinical and/or diagnostic complications.
INFECTION CONTROL
|
|
|
1/24/22
|
Khalid MF, Selvam K, Jeffry AJN, et al. | Diagnostics
Aim: To evaluate the pooled sensitivity and specificity of the commercially available RATs. UPDATED
DIAGNOSTICS
|
|
|
1/24/22
|
Miller JL, Tada M, Goto M, et al. | Acad Emerg Med
Aim: To evaluate published reports of prediction models for severe illnesses caused COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/24/22
|
Jaljaa A, Caminada S, Tosti ME, et al. | BMC Public Health
Aim: To assess the risk of infection of migrants and ethnic minorities in the 53 countries belonging to the World Health Organization European Region, during the first year of the pandemic. UPDATED
|
|
|
1/24/22
|
Ledda C, Costantino C, Motta G, et al. | Trop Med Infect Dis
Aim: To provide evidence on mRNA reported vaccine breakthrough infections among HCP.
CLINICAL CHARACTERISTICS
|
|
|
1/24/22
|
Amiri-Dashatan N, Koushki M, Parsamanesh N, et al. | J Investig Med
Aim: To reassess the available findings on the association between cortisol level and severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
1/24/22
|
Latif J, Elizabeth Weekes C, Julian A, et al. | Clin Nutr ESPEN
Aim: To evaluate what evidence is available to inform evidence-based decision making on the nutritional care of patients hospitalised with COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
1/24/22
|
Chen Y, Li X, Dai Y, et al. | Front Endocrinol
Aim: To evaluate the effect of the severity of COVID-19 on thyroid-related hormones and the effect of thyroid-related hormones on the outcome of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/24/22
|
Korang SK, von Rohden E, Veroniki AA, et al. | PLoS One
Aim: To assess the effectiveness and safety of COVID-19 vaccines through analyses of all currently available randomized clinical trials. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/21/22
|
Bailey AJM, Kirkham AM, Monaghan M, et al. | Curr Oncol
Aim: To review the evidence on the clinical manifestations and outcomes of HCT recipients contracting COVID-19 at all stages following transplant, including both pediatric and adult recipients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/21/22
|
Pranata R, Yonas E, Huang I, et al. | Eur J Gastroenterol Hepatol
Aim: To explore the association between the FIB-4 index and the risk of mortality among COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/21/22
|
De Lorenzo A, Cenname G, Marchetti M, et al. | Eur Rev Med Pharmacol Sci
Aim: To highlight the relationship between nutritional quality and social inequalities related to CDNCD, obesity and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
1/21/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of Sotrovimab as a treatment for COVID-19.
|
|
|
1/21/22
|
Oliveira Carvalho P, Hülsdünker T, Carson F | Behav Sci
Aim: To determine the prevalence of anxiety, depression and stress during the coronavirus lockdown.
MENTAL HEALTH
|
|
|
1/20/22
|
Fujita-Rohwerder N, Beckmann L, Zens Y, et al. | BMJ Evid Based Med
Aim: To systematically assess the diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children under real-life conditions. UPDATED
DIAGNOSTICS
|
|
|
1/20/22
|
Viner R, Russell S, Saulle R, et al. | JAMA Pediatr
Aim: To review published reports on the association of school closures during broader social lockdown with mental health, health behaviors, and well-being in children and adolescents aged 0 to 19 years, excluding associations with transmission of infection.
MENTAL HEALTH
|
|
|
1/19/22
|
Peng J, She X, Mei H, et al. | Aging
Aim: To explore and summarize the association between treatment with tocilizumab and clinical outcomes in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
1/19/22
|
Sarfraz Z, Sarfraz A, Sarfraz M, et al. | Ann Med Surg
Aim: To identify the causative factors of contact dermatitis from PPE and hygiene practices.
INFECTION CONTROL
|
|
|
1/19/22
|
Wong K, Farooq Alam Shah MU, Khurshid M, et al. | Ann Med Surg
Aim: To analyze the association of COVID-19 with vasculitis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/19/22
|
George TP, Joy SS, Rafiullah M, et al. | Curr Diabetes Rev
Aim: To look into cytokine levels, prevalence of risk factors, and other comorbidities in COVID-19 patients with and without diabetes mellitus during the early COVID-19 outbreak.
CLINICAL CHARACTERISTICS
|
|
|
1/19/22
|
Haas JW, Bender FL, Ballou S, et al. | JAMA Netw Open
Aim: To compare the frequencies of AEs reported in the placebo groups of COVID-19 vaccine trials with those reported in the vaccine groups. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/19/22
|
Qin R, He L, Yang Z, et al. | Clin Rev Allergy Immunol
Aim: To provide an updated synthesis of the association between immune-related indicators and COVID-19 prognosis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/19/22
|
Masuda Y, Teoh SE, Yeo JW, et al. | Sci Rep
Aim: To investigate the effect of the COVID-19 pandemic on the pre-hospital chain of survival. UPDATED
|
|
|
1/18/22
|
Espinoza-Espinoza DAK, Dulanto-Vargas JA, Cáceres-LaTorre OA, et al. | J Int Soc Prev Community Dent
Aim: To evaluate the available evidence about a potential association between PD and the risk of COVID-19 complications. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/18/22
|
Caruso R, Annaloro C, Arrigoni C, et al. | Acta Biomed
Aim: To systematically synthesize evidence regarding burnout and post-traumatic stress disorder (PTSD) among nurses engaged in the frontline during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
1/18/22
|
Ao G, Wang Y, Liu F, et al. | Exp Clin Transplant
Aim: To compare the clinical outcomes between kidney transplant recipients and patients on dialysis with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/18/22
|
Zhang S, Yang Z, Chen ZL, et al. | Evid Based Complement Alternat Med
Aim: To systematically evaluate the efficacy and safety of TMTP for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/18/22
|
Krishnaratne S, Littlecott H, Sell K, et al. | Cochrane Database Syst Rev
Aim: To assess the effectiveness of measures implemented in the school setting to safely reopen schools, or keep schools open, or both, during the COVID-19 pandemic. UPDATED
INFECTION CONTROL
|
|
|
1/18/22
|
| National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk factors associated with severe COVID-19 outcomes in children 12 years and under. UPDATED
|
|
|
1/18/22
|
Kumar A, Rai A, Khan MS, et al. | J Tradit Complement Med
Aim: To review the evidence on the efficacy and side effects of herbal medicine supplementation with Western medicine in the treatment of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/18/22
|
Heneghan CJ, Spencer EA, Brassey J, et al. | F1000Res
Aim: To systematically review the evidence on orofecal SARS-CoV-2 transmission. UPDATED
|
|
|
1/17/22
|
Alharbi MG | Expert Rev Hematol
Aim: To review the evidence on COVID-19 infection associated with ITP.
CLINICAL CHARACTERISTICS
|
|
|
1/17/22
|
Lan SH, Lee HZ, Chao CM, et al. | J Med Virol
Aim: To investigate the effect of melatonin on clinical outcomes in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
1/17/22
|
Hermansyah TA, Ginanjar E, Putri VH | Acta Med Indones
Aim: To summarize the prognosis of Corona Virus Disease 2019 (COVID-19) patients with elevated troponin and N-terminal pro brain natriuretic peptide (NT-proBNP) levels and demonstrate the involvement of myocardial injury as a complication in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/17/22
|
Shahzad M, Chaudhary SG, Zafar MU, et al. | Transpl Infect Dis
Aim: To investigate the impactof COVID-19 in HSCT recipients, including the severity of symptoms, treatment modalities used, and prognosis.
CLINICAL CHARACTERISTICS
|
|
|
1/17/22
|
Danwang C, Noubiap JJ, Robert A, et al. | AIDS Res Ther
Aim: To summarize the available information on the risk of hospitalization, severe disease, and death attributable to HIV in patients with COVID-19 and to determine the proportion of patients co-infected with HIV among patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/17/22
|
Singh A, Singh Y, Pangasa N, et al. | Indian J Crit Care Med
Aim: To highlight the risk factors, types, and outcomes of air leak in COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/17/22
|
Cao XJ, Fang KY, Zhou J, et al. | J Virol Methods
Aim: To review the evidence on the performance of commercial Cepheid Xpert Xpress SARS-CoV-2 test for the identification of SARS-CoV-2.
DIAGNOSTICS
|
|
|
1/14/22
|
Suh S, Lee S, Gym H, et al. | BMC Infect Dis
Aim: To discover the related SNPs of SARS-CoV-2 infection.
INFECTION CONTROL
|
|
|
1/14/22
|
Rosário Ferreira ME, Santos de Andrade AV, Ferreira Queiroz AA, et al. | EXCLI J
Aim: To review the evidence on the clinical and laboratory characteristics, associated comorbidities, and outcomes of obese patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/14/22
|
Galmiche S, Nguyen LBL, Tartour E, et al. | Clin Microbiol Infect
Aim: To assess immunogenicity, efficacy and effectiveness of COVID-19 vaccines in immunocompromised populations.
INFECTION CONTROL
|
|
|
1/14/22
|
Kim DH, Basurrah MA, Han JH, et al. | Saudi Med J
Aim: To evaluate the diagnostic utility of self-collected saliva in coronavirus desease-19 (COVID-19) screening procedures.
DIAGNOSTICS
|
|
|
1/13/22
|
Joshi R, Singla R, Mishra A, et al. | New Microbes New Infect
Aim: To assess the possibility of re-infection in discharged patients and the risk of the transmission, proficiency of RT-PCR results and approximate period required for the quarantine and the real challenges for the development of vaccine.
INFECTION CONTROL
|
|
|
1/13/22
|
Abbaspur-Behbahani S, Monaghesh E, et al. | Health Policy Technol
Aim: To synthesize the capabilities of m-health in providing health services to the elderly during the COVID-19 pandemic, and to identify the factors contributing to the success of these tools.
INFECTION CONTROL
|
|
|
1/13/22
|
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19.
CLINICAL CHARACTERISTICS
|
|
|
1/13/22
|
Reddy SGK, Mantena M, Garlapati SKP, et al. | J Pharm Bioallied Sci
Aim: To determine the pooled estimations in the clinical features and prognosis along with the subgroups based on the severity of the disease in various regions of the world.
CLINICAL CHARACTERISTICS
|
|
|
1/13/22
|
Macpherson K, Cooper K, Harbour J, et al. | BMJ Open
Aim: To explore the experiences of people living with long COVID and how they perceive the healthcare services available to them.
CLINICAL CHARACTERISTICS
|
|
|
1/13/22
|
Zintel S, Flock C, Arbogast AL, et al. | Z Gesundh Wiss
Aim: To investigate whether there are systematic gender differences in the intention to get vaccinated against COVID-19.
INFECTION CONTROL
|
|
|
1/13/22
|
Soltani S, Zandi M, Ahmadi SE, et al. | Iran J Med Sci
Aim: To identify ophthalmic symptoms of COVID-19 patients and establish an association between these symptoms and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
1/13/22
|
Williams BE, Kondo KK, Ayers CK, et al. | Health Equity
Aim: To identify interventions that have effectively reduced disparities in health outcomes in infectious disease outbreaks or natural disasters in the United States and understand whether such interventions could be applied to reduce health disparities in the current COVID-19 pandemic. VA ESP
|
|
|
1/12/22
|
Dzinamarira T, Murewanhema G, Mhango M, et al. | Int J Environ Res Public Health
Aim: To map and analayse the available global evidence on the prevalence of SARS-CoV-2 infections among healthcare workers.
CLINICAL CHARACTERISTICS
|
|
|
1/12/22
|
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/12/22
|
Zuin M, Roncon L, Zuliani G. | J Cardiovasc Med
Aim: To compare the echocardiographic systolic pulmonary arterial pressure (sPAP) difference between COVID-19 survivors (S) and nonsurvivors (NS).
CLINICAL CHARACTERISTICS
|
|
|
1/12/22
|
Elharake JA, Akbar F, Malik AA, et al. | Child Psychiatry Hum Dev
Aim: To learn about the impact of the COVID-19 pandemic on the mental health of children, adolescents, and college students.
MENTAL HEALTH
|
|
|
1/12/22
|
Niquini RP, Corrêa da Mota J, Bastos LS, et al. | Sci Rep
Aim: To assess HCV infection rates in haemodialysis patients in Brazil.
|
|
|
1/12/22
|
Liyanage S, Saqib K, Khan AF, et al. | Int J Environ Res Public Health
Aim: To estimate the global prevalence of anxiety among university students during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
1/12/22
|
Reis S, Popp M, Schmid B, et al. | J Clin Med
Aim: To determine the safety and efficacy of intensified anticoagulation with intermediate or therapeutic doses compared to standard-dose thromboprophylaxis in hospitalised patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
1/11/22
|
Salman MA, Mallah SI, Khalid W, et al. | Int J Gen Med
Aim: To investigate the clinical characteristics of patients whose cerebrospinal fluid (CSF) tested positive for SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Pranata R, Huang I, Lim MA, et al. | Front Med
Aim: To assess whether elevated De Ritis ratio is associated with poor prognosis in patients with coronavirus 2019 (COVID-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Xavier-Santos D, Padilha M, Fabiano GA, et al. | Trends Food Sci Technol
Aim: To provide insights and perspectives for the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention/treatment and/or modulation of the microbiota in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
1/11/22
|
Janmohamed K, Walter N, Nyhan K, et al. | J Health Commun
Aim: To evaluate the relative impact of interventions designed to mitigate COVID-19-related misinformation.
INFECTION CONTROL
|
|
|
1/11/22
|
Shrestha DB, Sedhai YR, Budhathoki P, et al. | Ann Med Surg
Aim: To assess the value and significance of spontaneous pulmonary barotrauma such as pneumothorax, pneumomediastinum, and subcutaneous emphysema in patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Schlage S, Lehrnbecher T, Berner R, et al. | Eur J Pediatr
Aim: To update the available information on SARS-CoV-2 infections in pediatric cancer patients.
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Hernández-Vásquez A, Chavez-Ecos F, Barrenechea-Pulache A, et al. | PeerJ
Aim: To estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Ogungbe O, Kumbe B, Fadodun O, et al. | Int J Cardiol Heart Vasc
Aim: To quantify the association between biomarkers of myocardial injury (troponin), myocardial stretch (NT-proBNP, Gal-3), coagulation (D-Dimer), inflammation (CRP, IL-6) and severe COVID-19 or death in hospitalized patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Marchand G, Patil AS, Masoud AT, et al. | AJOB Glob Rep
Aim: To review the evidence on the maternal and neonatal outcomes in pregnant women infected with the Coronavirus Disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Hada M, Mosholder AD, Leishear K, et al. | Neurol Sci
Aim: To examine the available data on U.S. therapies approved to treat MS and the risk of SARS-CoV-2 infection or severe COVID-19 outcomes.
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Zeynali Bujani M, Behnampour M, Rahimi N, et al. | Malays J Med Sci
Aim: To review the evidence on the effect of influenza vaccination on the prevention of COVID-19 and its consequences in patients.
INFECTION CONTROL
|
|
|
1/11/22
|
Carbone EA, de Filippis R, Roberti R, et al. | Front Psychol
Aim: To systematically review the psychological consequences of the COVID-19 lockdown in caregivers of patients with cognitive impairment and dementia and the impact on the health of their patients.
MENTAL HEALTH
|
|
|
1/11/22
|
Mahmoudi E, Mollazadeh R, Mansouri P, et al. | Clin Cardiol
Aim: To evaluate electrocardiogram (ECG) markers of repolarization heterogeneity in patients hospitalized with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/11/22
|
Chiodini I, Gatti D, Soranna D, et al. | Front Public Health
Aim: To investigate whether vitamin D status is associated with the COVID-19 severity, defined as ARDS requiring admission to intensive care unit (ICU) or mortality (primary endpoints) and with the susceptibility to SARS-CoV-2 and COVID-19-related hospitalization (secondary endpoints).
CLINICAL CHARACTERISTICS
|
|
|
1/10/22
|
Strasser MA, Sumner PJ, Meyer D | J Affect Disord
Aim: To synthesise the research findings on the relationship between COVID-19 news and distress in young people.
MENTAL HEALTH
|
|
|
1/10/22
|
Bakr AM, El-Sakka AI, et al. | Int J Impot Res
Aim: To review the evidence on the change in erectile function among patients and health care providers during the COVID-19 pandemic. UPDATED
|
|
|
1/10/22
|
Omar M, Youssef MR, Trinh LN, et al. | Birth
Aim: To evaluate variations in clinical presentation, laboratory findings, and maternal/neonatal outcomes in COVID-19 patients who delivered vaginally versus via cesarean.
CLINICAL CHARACTERISTICS
|
|
|
1/10/22
|
Saengsiwaritt W, Jittikoon J, Chaikledkaew U, et al. | Rev Med Virol
Aim: To clarify associations of genetic variants in those genes with COVID-19 susceptibility and severity.
|
|
|
1/10/22
|
Aria H, Mahmoodi F, Ghaheh HS, et al. | Anal Biochem
Aim: To review research studies that have applied nanobodies to diagnose or neutralize SARS-CoV-2.
DIAGNOSTICS
|
|
|
1/10/22
|
Vera San Juan N, Clark SE, Camilleri M, et al. | BMJ Open
Aim: To provide a detailed understanding of redeployment and training during the first year of the COVID-19 pandemic by capturing and considering the merit of the strategies enlisted and the experiences and needs of redeployed healthcare workers (HCWs).
|
|
|
1/10/22
|
| COVID-END
Aim: To inform guidance on KN95 masks usage and approaches to improving the fit and performance of KN95s in optimal settings in hospitals.
INFECTION CONTROL
|
|
|
1/8/22
|
Edwards A, Cooper A, Lewis R, et al. | Wales COVID-19 Evidence Centre
Aim: To review the evidence on the transmission risk of SARS-CoV-2 from vaccinated people to unvaccinated or vaccinated people.
|
|
|
1/7/22
|
Yu R, Zhang S, Zhao D, et al. | Expert Rev Mol Med
Aim: To compare the outcomes of COVID-19 patients treated with Integrated Chinese with Western Medicine versus Western Medicine alone.
CANDIDATE THERAPEUTICS
|
|
|
1/7/22
|
Alzahrani F, Alshahrani NZ, Sabah AA, et al. | Psych J
Aim: To review the prevalence and associated factors of common mental disorders (i.e., depression, anxiety, and stress) related to the pandemic among the Saudi general population.
MENTAL HEALTH
|
|
|
1/6/22
|
Bielski K, Makowska K, Makowski A, et al. | Cardiol J
Aim: To update the information about the impact of coronavirus disease 2019 (COVID-19) pandemic on outcomes of in-hospital cardiac arrest (IHCA).
|
|
|
1/6/22
|
Amirian A, Pakzad R, Hasanpour V, et al. | J Matern Fetal Neonatal Med
Aim: To investigate neonatal outcomes among pregnant women with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/6/22
|
MarraMS ARM, Kobayashi T, Suzuki H, et al. | J Infect
Aim: To review the evidence on the impact of COVID-19 vaccination on neutralizing antibodies and the short-term effectiveness of COVID-19 vaccines among immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 infection. UPDATED
INFECTION CONTROL
|
|
|
1/5/22
|
Thatiparthi A, Liu J, Martin A, et al. | J Clin Aesthet Dermatol
Aim: To review the evidence on adverse facial reactions associated with use of face masks during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
1/5/22
|
Molaee H, Emadi SN, M'Imunya JMN, et al. | Dermatol Ther
Aim: To investigate chilblain-like lesions in children during the COVID-19 pandemic, any predisposition, location, clinical course, and prognosis.
CLINICAL CHARACTERISTICS
|
|
|
1/5/22
|
Matar RH, Than CA, Nakanishi H, et al. | Blood Coag Fibrinolysis
Aim: To investigate the outcomes of patients with thromboembolic events following the AstraZeneca vaccine (ChAdOx1 nCoV-19, AZD1222).
INFECTION CONTROL
|
|
|
1/5/22
|
Cui Y, Zhao B, Li T, et al. | Brain Res Bull
Aim: To evaluate the association between the risk of ischemic stroke and COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/4/22
|
Azeez TA, Lakoh S, Adeleke AA, et al. | Indian J Pharmacol
Aim: To provide evidence for the use of ivermectin to prevent COVID-19 among hospital workers in low-resource countries.
INFECTION CONTROL
|
|
|
1/4/22
|
Bhattacharyya A, Sarma P, Kaur H, et al. | Indian J Pharmacol
Aim: To review the evidence on the demographic and clinical profile, risk factors, impact of different interventions, and outcomes among C-ROCM cases.
CLINICAL CHARACTERISTICS
|
|
|
1/4/22
|
Sholzberg M, da Costa BR, Tang GH, et al. | Res Pract Thromb Haemost
Aim: To determine the effects of therapeutic heparin in hospitalized patients with COVID?19.
CANDIDATE THERAPEUTICS
|
|
|
1/4/22
|
Kow CS, Ramachandram DS, Hasan SS | J Med Virol
Aim: To summarize the overall effectiveness of mRNA-1273 vaccine against COVID-19 caused by delta variant.
INFECTION CONTROL
|
|
|
1/3/22
|
Ceban F, Ling S, Lui LMW, et al. | Brain Behav Immun
Aim: To quantify the proportion of individuals experiencing fatigue and cognitive impairment 12 or more weeks following COVID-19 diagnosis, and to characterize the inflammatory correlates and functional consequences of post-COVID-19 syndrome. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Changal K, Veria S, Mack S, et al. | BMC Cardiovasc Disord
Aim: To review the evidence on the effect of myocardial injury on the clinical outcome of patients hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Kheyrandish S, Rastgar A, Arab-Zozani M, et al. | Front Med
Aim: To review the evidence on portal vein thrombosis development through COVID-19 infection or vaccination.
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Jahan N, Brahma A, Kumar MS, et al. | Int J Infect Dis
Aim: To summarize the seroprevalence of SARS-CoV-2 and quantitatively estimate the pooled seroprevalence of SARS-CoV-2 among the Indian population. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
1/3/22
|
Kow CS, Lee LH, Ramachandram DS, et al. | Immun Inflamm Dis
Aim: To investigate the effect of colchicine in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
1/1/22
|
| Wales COVID-19 Evidence Centre
Aim: To review the evidence on the barriers and facilitators for adopting PPBs in various settings.
|
|
|
12/31/21
|
Ge J, Ma Y, Wu Z, et al. | Medicine
Aim: To better inform efforts to treat and control the current outbreak with effective anticoagulant treatment strategies for coronavirus disease 2019 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/31/21
|
Zulkarnain Z, Nuryati A, Upix D, et al. | Journal of Health Policy and Management
Aim: To examine the association between gender and anxiety among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/31/21
|
Al-Ali D, Elshafeey A, Mushannen M, et al. | J Cell Mol Med
Aim: To examine all the reported cardiovascular and haematological events post COVID-19 vaccination in published literature and to suggest possible mechanisms to explain these rare phenomena.
INFECTION CONTROL
|
|
|
12/31/21
|
Jaiswal V, Alquraish D, Sarfraz Z, et al. | J Prim Care Community Health
Aim: To provide thorough analyses of associations between COVID-19 and neurological outcomes for patients with PD.
CLINICAL CHARACTERISTICS
|
|
|
12/30/21
|
Chiu L, Lo C, Shen M, et al. | PLoS One
Aim: To report on the state of the current literature on the use of colchicine in COVID-19 and to investigate the reported clinical outcomes in COVID-19 patients by colchicine usage. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/30/21
|
Chen Y, Li L, Zhang Q, et al. | Medicine
Aim: To evaluate the epidemiology, methodological quality, and reporting characteristics of published SRs/meta-analyses related to COVID-19.
INFECTION CONTROL
|
|
|
12/30/21
|
Fresna RH, Atikah SN, Salsabila MM, et al. | J Health Policy Management
Aim: To review the evidence on gender issues in mental health responses by health workers.
INFECTION CONTROL
|
|
|
12/30/21
|
Wang F, Boros S | Baltic Journal of Health and Physical Activity
Aim: To review the evidence of mental and physical health consequences during COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
12/30/21
|
Baez-Ferrer N, Bompart-Cairos A, Lopez-Rial D, et al. | Cardiomyopathy and Heart Failure
Aim: To analyze the mortality of patients with ARDS due to SARS-CoV-2 who required ECMO.
CANDIDATE THERAPEUTICS
|
|
|
12/30/21
|
Sarwoko TA, Bahri AS | J Matern Child Health
Aim: To determine the effect of the COVID-19 pandemic lockdown on the physical activity and sleeping habits of children and adolescents.
INFECTION CONTROL
|
|
|
12/30/21
|
Ahmed S, Mansoor M, Shaikh MS, et al. | Indian J Crit Care Med
Aim: To evaluate the global scientific literature on the utility of plasma presepsin (PSP) as a prognostic biomarker in a homogeneous group of coronavirus disease 2019 (COVID-19) positive cases.
INFECTION CONTROL
|
|
|
12/30/21
|
Ali NA, Khoja A, Kazim F | Turk Psikiyatri Derg
Aim: To highlight the role of telemental health services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Dragioti E, Li H, Tsitsas G, et al. | J Med Virol
Aim: To quantify the mental health burden of COVID-19 pandemic.
MENTAL HEALTH
|
|
|
12/29/21
|
Khandker SS, Godman B, Jawad MI, et al. | Vaccines
Aim: To review the current vaccine candidates, focusing on their development strategy, adverse events, and effectiveness based on the published findings.
INFECTION CONTROL
|
|
|
12/29/21
|
Jang W, Kim B, Kim ES, et al. | J Korean Med Sci
Aim: To investigate how effectively national and international guidelines provide recommendations for infection control issues in hospitals.
INFECTION CONTROL
|
|
|
12/29/21
|
Akbari A, Razmi M, Sedaghat A, et al. | Expert Rev Anti Infect Ther
Aim: To assess the comparative effectiveness of pharmacological agents in published RCTs.
CANDIDATE THERAPEUTICS
|
|
|
12/29/21
|
Oliveira MR, Sudati IP, Konzen VM, et al. | Exp Gerontol
Aim: To evaluate the available evidence related to the level of physical activity (PA) of elderly people during the COVID-19 pandemic. UPDATED
|
|
|
12/29/21
|
Akyol M, Çevik E, Ucku D, et al. | Tuberk Toraks
Aim: To analyze the antibody responses after a full series of mRNA-based SARS-CoV-2 vaccination in kidney transplantation and dialysis patients.
INFECTION CONTROL
|
|
|
12/29/21
|
Guan Z, Chen C, Li Y, et al. | Front Public Health
Aim: To evaluate the impact of coinfection with SARS-CoV-2 and influenza on mortality, critical outcomes involving shock, being admitted to ICU or requiring ventilatory support, as well as relevant clinical symptoms and laboratory index compared with mono-infections of SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Lee YK, Huang YH | Vaccines
Aim: To help clinicians recognize the possible manifestations and systemic pathogenesis, especially those related to the eye, after receiving COVID-19 vaccination.
INFECTION CONTROL
|
|
|
12/29/21
|
Zhu J, Racine N, Xie EB, et al. | Front Psychiatry
Aim: To examine the global prevalence of clinically significant depression and anxiety among post-secondary students during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
12/29/21
|
Ma KS, Lee CC, Liu KJ, et al. | Pathogens
Aim: To evaluate strategies for augmentation of host immunity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
CANDIDATE THERAPEUTICS
|
|
|
12/29/21
|
Dashti S, Bolghanabadi N, Ghavami V, et al. | J Sex Marital Ther
Aim: To review the evidence on the impact of the COVID-19 pandemic on female sexual function.
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Viner R, Waddington C, Mytton O, et al. | J Infect
Aim: To review the evidence on the extent that children and young people (CYP) under 20 years of age transmit SARS-CoV-2 to other CYP and to adults in household and child-specific (e.g. educational) settings. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/29/21
|
Tentolouris N, Samakidou G, Eleftheriadou I, et al. | Diabetes Metab Res Rev
Aim: To investigate the effect of vitamin D supplementation on mortality and admission to intensive care unit (ICU) of COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
12/29/21
|
Racine N, Eirich R, Cooke J, et al. | Infant Ment Health J
Aim: To identify the prevalence of depression and anxiety in parents of young children ( UPDATED
MENTAL HEALTH
|
|
|
12/29/21
|
Amanollahi A, Sotoodeh Ghorbani S, Basir Ghafouri H, et al. | Med J Islam Repub Iran
Aim: To systematically assess and estimate the clinical, laboratory, and imaging features related to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Makoah NA, Tipih T, Litabe MM, et al. | Future Virol
Aim: To investigate the utility of serological tests for the diagnosis of COVID-19 during the first week of symptom onset in patients confirmed with the real-time RT-PCR.
DIAGNOSTICS
|
|
|
12/27/21
|
Jennings G, Monaghan A, Xue F, et al. | J Clin Med
Aim: To compare the two phases of long COVID, namely ongoing symptomatic COVID-19 and post-COVID-19 syndrome with respect to symptomatology, abnormal functioning, psychological burden, and quality of life. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Sessa F, Salerno M, Esposito M, et al. | J Clin Med
Aim: To clarify the major aspects of fatal adverse effects related to COVID-19 vaccines.
INFECTION CONTROL
|
|
|
12/27/21
|
Cuevas-Gonzalez MV, Espinosa-Cristóbal LF, Donohue-Cornejo A, et al. | Medicine
Aim: To identify the main signs and symptoms of COVID-19 in the oral cavity. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Zein AFMZ, Raffaello WM | Prim Care Diabetes
Aim: To synthesize the latest evidence on the effect of dipeptidyl peptidase-4 (DPP-IV) inhibitor in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/27/21
|
Pang KW, Tham SL, Ng LS | Life
Aim: To determine the pooled sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-) and diagnostic odds ratio (DOR) of using GD as a triage symptom prior to RT-PCR.
DIAGNOSTICS
|
|
|
12/27/21
|
Moreno-Sánchez E, Castillo-Viera E, Vélez-Moreno E, et al. | Medicina
Aim: To analyse the factors that affect the probability of the paediatric asthma population suffering from COVID-19 or SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Stoicescu ER, Ciuca IM, Iacob R, et al. | Diagnostics
Aim: To assess the evidence on the utility of lung ultrasound (LUS) in neonates diagnosed with COVID-19.
DIAGNOSTICS
|
|
|
12/27/21
|
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G | Cells
Aim: To analyze the current data regarding the new-onset systemic and rheumatic autoimmune diseases in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Menezes RG, Rizwan T, Saad Ali S, et al. | Leg Med
Aim: To identify studies reporting gross, histological, microscopic, and immunohistochemical findings on postmortem examination of COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/27/21
|
Lieneck C, Bosworth M, Weaver E, et al. | Medicina
Aim: To investigate underlying themes (constructs) surrounding influences upon the U.S. population’s mental health distress as experienced during the COVID-19 pandemic to date.
MENTAL HEALTH
|
|
|
12/27/21
|
Khoshrounejad F, Hamednia M, Mehrjerd A, et al. | Front Public Health
Aim: To explore more specific properties of telehealth-based services, which were developed to support patients suspected of or afflicted with COVID-19 and healthcare providers.
INFECTION CONTROL
|
|
|
12/27/21
|
Golpour M, Mousavi T, Alimohammadi M, et al. | Int J Immunopathl Pharmacol
Aim: To evaluate the efficacy of Colchicine in the treatment of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/27/21
|
Kwak SG, Choo YJ, Chang MC | Complement Ther Med
Aim: To investigate the therapeutic effect of high-dose intravenous vitamin C (HDIVC) in patients with coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
12/27/21
|
Huerta-González S, Selva-Medrano D, López-Espuela F, et al. | Int J Environ Res Public Health
Aim: To analyze and synthesize qualitative studies that investigate the perceptions of nurses about the psychological impacts of treating hospitalized people with COVID-19 on the front line.
MENTAL HEALTH
|
|
|
12/24/21
|
Chen H, Yang G, Long Y, et al. | Evid Based Complement Alternat Med
Aim: To determine the role of lymphocyte and platelet counts as well as interleukin-6 levels as predictors of death in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Rico-Martin S, Calderon-Garcia JF, Basilio-Fernandez B, et al. | J Cardiovasc Dev Dis
Aim: To investigate the relationship between metabolic syndrome (MetS) and its components with SARS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the COVID-19 variant of concern dubbed Omicron. UPDATED
|
|
|
12/24/21
|
Bradley SA, Banach M, Alvarado N, et al. | J Diabetes
Aim: To determine the prevalence of diabetes in hospitalized COVID-19 patients and investigate the association of diabetes severe COVID-19, rate of acute respiratory distress syndrome (ARDS), mortality, and need for mechanical ventilation.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Cai X, Wu G, Zhang J, et al. | Front Med
Aim: To analyse the risk factors for AKI in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
McIntyre KM, Favre NM, Kuo CC, et al. | Cureus
Aim: To identify novel coronavirus disease 2019 (COVID-19) patients with a diagnosis of sudden sensorineural hearing loss (SSNHL) with an aim to describe possible mechanisms.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Tomerak S, Khan S, Almasri M, et al. | Scand J Immunol
Aim: To compile clinical data of COVID-19 patients who developed thrombotic complications to investigate the possible role of hyperinflammation in inducing hypercoagulation.
CLINICAL CHARACTERISTICS
|
|
|
12/24/21
|
Wang J, Tong Y, Li D, et al. | Front Immunol
Aim: To analyze the difference of adverse events (AEs) rate and virus geometric mean titer (GMT) values between young and older people.
INFECTION CONTROL
|
|
|
12/23/21
|
Izcovich A, Peiris S, Ragusa M, et al. | J Clin Epidemiol
Aim: To summarize the best available evidence on ivermectin for prevention and treatment of COVID-19 patients and explore potential explanations for heterogeneity in RCTs results with focus on studies methodological limitations.
CANDIDATE THERAPEUTICS
|
|
|
12/23/21
|
Katsanos A, Palaiodimou L, Zand R, et al | Stroke
Aim: To evaluate the impact of COVID-19 pandemic on stroke epidemiology and care across the world. UPDATED
|
|
|
12/23/21
|
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review the evidence from interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Bastos SNMAN, Barbosa BLF, Cruz LGB, et al. | Rev Bras Ginecol Obstet
Aim: To analyze the clinical and obstetric aspects of pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Agarwal N, Mishra S, Ayub A | J Family Med Prim Care
Aim: To find out the impact on the discharge status from hospital of the patients receiving convalescent plasma therapy. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/23/21
|
Ebrahimi Chaharom F, Pourafkari L, Ebrahimi Chaharom AA, et al. | Pulm Pharmacol Ther
Aim: To evaluate the impact of corticosteroids on the mortality rate, HLOS, ICU admission, intubation, and mechanical ventilation in Covid-19 patients with severe pneumonia.
CANDIDATE THERAPEUTICS
|
|
|
12/23/21
|
Mehrdad R, Zahra K, Mansouritorghabeh H | Clin Appl Thromb Hemost
Aim: To determine the levels of fibrinogen, D-dimer and FDP in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Wang Y, Liu Y | Prev Med Rep
Aim: To summarize multilevel determinants of COVID-19 vaccination intention in the US to inform future intervention opportunities.
INFECTION CONTROL
|
|
|
12/23/21
|
Otunla A, Rees K, Dennison P, et al. | BMJ Evid Based Med
Aim: To determine if and to what degree asthma may predispose to worse COVID-19 outcomes in order to inform treatment and prevention decisions, including shielding and vaccine prioritisation.
CLINICAL CHARACTERISTICS
|
|
|
12/23/21
|
Chiem C, Alghamdi K, Nguyen T, et al. | Transfus Med Hemother
Aim: To review the evidence on the impact of the COVID-19 pandemic on blood transfusion services.
INFECTION CONTROL
|
|
|
12/22/21
|
Agrawal S, Goel AD, Gupta N, et al. | Heart Lung
Aim: To assess the diagnostic yield of BAL for detection of SARS-CoV-2 in cases of non-diagnostic upper respiratory tract samples.
DIAGNOSTICS
|
|
|
12/22/21
|
Hussain N, Agarwala P, Iqbal K, et al. | J Med Virol
Aim: To compile and illustrate the clinical characteristics, physical examination findings, outcomes, and possible pathology behind acute TE occurring in COVID-19 recovered patients.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Guo J, Qin Z, Lau NC, et al. | Am J Chin Med
Aim: To evaluate the efficacy and safety of Chinese medicine (CM) against COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/22/21
|
Koupaei M, Naimi A, Moafi N, et al. | Front Med
Aim: To evaluate the various aspects such as symptoms, diagnosis, treatment, and mortality rate.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Alvarenga MOP, Veloso SRM, Bezerra ALCA, et al. | J Photochem Photobiol
Aim: To analyze the evidence from trials performed in healthcare facilities that assessed UV-C disinfection's ability to reduce manual cleaning failures enhancing the logarithmic reduction of nosocomial pathogens. colonized on surfaces. UPDATED
INFECTION CONTROL
|
|
|
12/22/21
|
Vidya G, Kalpana M, Roja K, et al. | Maedica
Aim: To examine the evidence on the clinical presentation of COVID-19 in children.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Jafari M, Dastgheib SA, Ferdosian F, et al. | Hematol Transfus Cell Ther
Aim: To evaluate the proportion of hematological cancer patients with the SARS-CoV-2 infection during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
12/22/21
|
Mukherjee TI, Khan AG, Dasgupta A, et al. | Reprod Health
Aim: To systematically review empirical evidence of the indirect impacts of respiratory epidemics on SRH.
|
|
|
12/21/21
|
Sung K, Chang T, Wang Y, et al. | J Chin Med Assoc
Aim: To evaluate the efficacy and safety of SARS-CoV-2 vaccination in IBD patients. UPDATED
INFECTION CONTROL
|
|
|
12/20/21
|
Fazlollahi A, Zahmatyar M, Noori M, et al. | Rev Med Virol
Aim: To identify the clinical profile, investigations, and management of reported cardiac complications post-mRNA COVID-19 vaccines.
INFECTION CONTROL
|
|
|
12/20/21
|
Jacobs JW, Booth GS | Am J Clin Pathol
Aim: To summarize the epidemiologic, clinical, and laboratory characteristics of autoimmune hemolytic anemia (AIHA) secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination.
CLINICAL CHARACTERISTICS
|
|
|
12/20/21
|
Stainer A, Amati F, Suigo G, et al. | Semin Respir Crit Care Med
Aim: To describe clinical picture, disease severity, proposed treatment regimen, and response to vaccination in patients with different types and severity of immunosuppression.
CLINICAL CHARACTERISTICS
|
|
|
12/20/21
|
Koçak C | Iran J Public Health
Aim: To review the evidence on the importance of isolation and contact tracing, and what kinds of practices exist in different countries.
INFECTION CONTROL
|
|
|
12/20/21
|
Shafiq A, Salameh MA, Laswi I, et al. | J Clin Pharmacol
Aim: To identify reports of post-vaccination adverse neurological events.
INFECTION CONTROL
|
|
|
12/20/21
|
Deng D, Liang A, Chui JN, et al. | Nephrology
Aim: To evaluate the effect of the COVID-19 pandemic on access to healthcare for patients with CKD. UPDATED
|
|
|
12/20/21
|
AlAmodi AA, Al-Kattan K, Shareef MA | PLoS One
Aim: To form a preliminary and contemporary understanding of the general public knowledge, attitude, and behaviors towards the COVID-19 pandemic globally.
INFECTION CONTROL
|
|
|
12/20/21
|
Romero Starke K, Reissig D, Petereit-Haack G, et al. | BMJ Glob Health
Aim: To quantify the isolated effect of age on hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/20/21
|
Carbone L, Di Girolamo R, Mappa I, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To evaluate the evidence from the literature regarding the acceptance rate of the SARS-CoV-2 vaccine in pregnant and breastfeeding women.
INFECTION CONTROL
|
|
|
12/17/21
|
Gagelmann N, Passamonti F, Wolschke C, et al. | Haematologica
Aim: To systematically analyse the outcomes of patients with haematological malignancies who received vaccination and to identify specific groups with differences in outcomes.
CLINICAL CHARACTERISTICS
|
|
|
12/17/21
|
Bilotta C, Perrone G, Adelfio V, et al. | Front Immunol
Aim: To analyze published cases of thrombosis after COVID-19 vaccinations to identify patients’ features, potential pathophysiological mechanisms, timing of appearance of the adverse events, and other critical issues.
CLINICAL CHARACTERISTICS
|
|
|
12/17/21
|
Castillo-Perez M, Jerjes-Sanchez C, Castro-Varela A, et al. | Thromb J
Aim: To determine the therapeutic trends and outcomes in VTE COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/17/21
|
Omer AAA | J Educ Health Promot
Aim: To review the perspectives of general surgical practice during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
12/17/21
|
Arabpour E, Khoshdel S, Tabatabaie N, et al. | Front Med
Aim: To evaluate the safety and efficacy of stem cells in treating patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/17/21
|
Crichton ML, Goeminne PC, Tuand K, et al. | Eur Respir Rev
Aim: To show the impact of different COVID-19 therapeutics on mortality in hospitalised patients.
CANDIDATE THERAPEUTICS
|
|
|
12/17/21
|
Dhillon RA, Qamar MA, Gilani JA, et al. | Ann Med Surg
Aim: To assess the determinants and disease spectrum of COVID-19 reinfection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/16/21
|
Bertini P, Guarracino F, Falcone M, et al. | J Cardiothorac Vasc Anesth
Aim: To summarize evidence from all available studies to assess the mortality of patients with COVID-19 treated with VV ECMO. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/16/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy of face masks in helping to prevent the spread of COVID-19. UPDATED
|
|
|
12/16/21
|
Impact of COVID-19 pandemic on haemorrhagic stroke admissions: a systematic review and meta-analysis
You Y, Niu Y, Sun F, et al. | BMJ Open
Aim: To evaluate the impact of the COVID-19 pandemic on stroke hospitalisations, especially haemorrhagic stroke.
CLINICAL CHARACTERISTICS
|
|
|
12/16/21
|
Mao YJ, Wang WW, Ma J, et al. | Chin Med J
Aim: To assess the incidence of SARS-CoV-2 reinfection and the protection effect of previous infection against reinfection.
CLINICAL CHARACTERISTICS
|
|
|
12/16/21
|
Abid MA, Abid MB | Hematol Oncol
Aim: To review the evidence on SARS-CoV-2 vaccine response in CAR T-cell therapy recipients.
INFECTION CONTROL
|
|
|
12/16/21
|
Raji H, Arjmand B, Rahim F | Adv Exp Med Biol
Aim: To evaluate the probable effect of the PBM therapy on the lung inflammation or ARDS and accelerate the regeneration of the damaged tissue.
CANDIDATE THERAPEUTICS
|
|
|
12/16/21
|
Waqar U, Ahmed S, Gardezi SMHA, et al. | Clin Appl Thromb Hemost
Aim: To explore the pathophysiology, epidemiology, diagnosis, management, and prognosis of TTS. UPDATED
INFECTION CONTROL
|
|
|
12/16/21
|
Rungjirajittranon T, Owattanapanich W, Leelakanok N, et al. | Clin Appl Thromb Hemost
Aim: To better understand the incidence of thrombosis, bleeding, and mortality rates among patients discharged after COVID-19 hospitalization.
CLINICAL CHARACTERISTICS
|
|
|
12/15/21
|
van Reekum EA, Rosic T, Sergeant A, et al. | J Med Case Rep
Aim: To synthesize neuropsychiatric outcomes of COVID-19 in people with preexisting psychiatric disorders.
CLINICAL CHARACTERISTICS
|
|
|
12/15/21
|
Ma Q, Liu J, Liu Q, et al. | JAMA Netw Open
Aim: To evaluate the percentage of asymptomatic infections among individuals undergoing testing (tested population) and those with confirmed COVID-19 (confirmed population).
CLINICAL CHARACTERISTICS
|
|
|
12/15/21
|
Dadras O, Afsahi AM, Pashaei Z, et al. | Immun Inflamm Dis
Aim: To systematically review the association between SARS-CoV-2 viral load and COVID-19 severity.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Khan S, Hasan SS, Bond SE, et al. | Expert Rev Anti Infect Ther
Aim: To review the evidence on the consumption of antimicrobials by patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/14/21
|
Abu-Amara J, Szpecht D, Al-Saad SR, et al. | Arch Med Sci
Aim: To assess the relationship of COVID-19 with the early gestational trimesters of pregnancy.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Hosseini SF, Behnam-Roudsari S, Alavinia G, et al. | J Res Med Sci
Aim: To determine whether clinicians used these scoring systems while assessing COVID-19 patients and the role of relevant biomarkers in disease severity and outcome.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Zuin M, Engelen MM, Barco S, et al. | Thromb Res
Aim: To estimate the incidence of VTE after hospital discharge among COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Naderi N, Rahimzadeh M | Virology
Aim: To determine whether KL-6 could be used as a prognostic factor for severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Szarpak L, Filipiak KJ, Skwarek A, et al. | Cardiol J
Aim: To determine the impact of AF/atrial flutter (AFL) on mortality, as well as individual complications in patients hospitalized with the coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
12/14/21
|
Dorri S, Sari F, Seyedhasani SN, et al. | Front Surg
Aim: To outline a guideline for preoperative screening before cancer surgeries and protecting health care workers during the pandemic.
INFECTION CONTROL
|
|
|
12/14/21
|
Zhang SX, Chen J | Eur J Psychotraumatol
Aim: To summarize the prevalence of anxiety, depression, and insomnia in the general adult population and healthcare workers (HCWs) in several key regions worldwide during the first year of the COVID pandemic.
MENTAL HEALTH
|
|
|
12/14/21
|
Bahji A, Bach P, Danilewitz M, et al. | Psychiatr Res Clin Pract
Aim: To synthesize evidence for interventions to support self?isolation and mandated quarantine for COVID?19 among individuals with SPMIs.
MENTAL HEALTH
|
|
|
12/14/21
|
Ruksakulpiwat S, Zhou W, Phianhasin L, et al. | Chronic Illn
Aim: To identify the difficulties that caregivers of chronically ill patients experienced during the COVID-19 pandemic and to provide directions for future studies. UPDATED
MENTAL HEALTH
|
|
|
12/14/21
|
Chahley ER, Reel RM, Taylor S | SSM Qual Res Health
Aim: To synthesize qualitative literature exploring the lived experience of healthcare workers (HCWs) who cared for patients during the following infectious disease outbreaks (IDOs): the 2003 SARS epidemic, 2009 H1N1 pandemic, 2012 MERS outbreak, and 2014 EVD epidemic.
MENTAL HEALTH
|
|
|
12/13/21
|
Burns KEA, Laird M, Stevenson J, et al. | JAMA Netw Open
Aim: To appraise the quality of clinical practice guidelines (CPGs) using the National Academy of Medicine (NAM) criteria. UPDATED
|
|
|
12/13/21
|
Ebrahimzadeh A, Mohseni S, Narimani B, et al. | Crit Rev Food Sci Nutr
Aim: To review the evidence on the association between vitamin D status and risk of COVID-19 in-hospital mortality among observational studies.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Pegollo L, Maggioni E, Gaeta M, et al. | Acta Biomed
Aim: To review the evidence on population DCT acceptance. UPDATED
INFECTION CONTROL
|
|
|
12/13/21
|
Wang Y, Yang J, Qiao F, et al. | Am J Infect Control
Aim: To systematically review the literature and conduct a meta-analysis of studies investigating the rate of HHC and the characteristics of HH during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
12/13/21
|
Ishak A, Al Rawashdeh MM, Esagian SM, et al. | J Clin Med
Aim: To assess the diagnostic performance of droplet digital PCR (ddPCR), also to evaluate its potential role in prognosis and management of COVID-19 patients.
DIAGNOSTICS
|
|
|
12/13/21
|
Damayanthi HDWT, Prabani KIP, Weerasekara I | Gerontol Geriatr Med
Aim: To identify various factors associated with mortality among older people infected with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Agolli A, Agolli O, Velazco DFS, et al. | Avicenna J Med
Aim: To understand the role of COVID-19 infection in causing pregnancy complications specifically fatal outcomes.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Kollias A, Kyriakoulis KG, Trontzas IP, et al. | J Clin Med
Aim: To assess the risk of in-hospital mortality in hospitalized patients with COVID-19 receiving high (intermediate or therapeutic) versus prophylactic doses of thromboprophylaxis. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
12/13/21
|
Alenezi FK, Almeshari MA, Mahida R, et al. | Ren Fail
Aim: To assess the incidence and risk factors of AKI, need for kidney replacement therapy (KRT), and mortality rate among COVID-19 patients with and without ARDS from the first wave of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of monoclonal antibodies for the treatment of COVID-19.
|
|
|
12/13/21
|
Orilisi G, Mascitti M, Togni L, et al. | Int J Environ Res Public Health
Aim: To investigate the frequency of oral manifestations in COVID-19 hospitalized patients.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Chen MY, Xiao FP, Kuai L, et al. | Am J Emerg Med
Aim: To provide a comprehensive description of the impact of AF on the prognosis of patients with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Sharma D, Bhaskar SMM | APMIS
Aim: To determine a pooled prevalence estimate of PHICs in paediatric and adolescent hospitalised patients admitted for treatment due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
Dissanayake HA, de Silva NL, Sumanatilleke M, et al. | J Clin Endocrinol Metab
Aim: To determine the association between vitamin D deficiency/insufficiency and susceptibility to COVID-19, its severity, mortality and role of vitamin D in its treatment.
CANDIDATE THERAPEUTICS
|
|
|
12/13/21
|
Abrokwa SK, Müller SA, Méndez-Brito A, et al. | PLoS One
Aim: To review the evidence on the extent and characteristics of reinfections and re-positive rates of SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/13/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the safety and efficacy of COVID-19 vaccination in renal dialysis patients.
|
|
|
12/13/21
|
Kokkotis G, Kitsou K, Xynogalas I, et al. | Aliment Pharmacol Ther
Aim: To investigate the impact of anti-TNF treatments on the clinical outcomes of COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
12/13/21
|
Pérez-Peralta L, Sauceda-Valenzuela AL, La Parra DR, et al. | Oman J Ophthamol
Aim: To identify preventive measures that will aid in reducing the risk of infection during standard appointments between patients and visual health professionals.
INFECTION CONTROL
|
|
|
12/13/21
|
Elisabeth AL, Karlen SB, Magkos F | Aging Dis
Aim: To conduct a thorough analysis of the current literature on the effects of the COVID-19-related lockdowns on diet and physical activity habits in older individuals. UPDATED
|
|
|
12/13/21
|
Bielski K, Szarpak A, Jaguszewski MJ, et al. | J Clin Med
Aim: To evaluate the influence of COVID-19 on OHCA survival outcomes.
|
|
|
12/13/21
|
Bursky M, Kosuri M, Walsh Carson K, et al. | Psychol Rep
Aim: To review the evidence on the benefits of various types of meditation and MBIs for inmates and individuals in lockdown or quarantine.
MENTAL HEALTH
|
|
|
12/9/21
|
Matta A, Kunadharaju R, Osman M, et al. | Cureus
Aim: To assess the demographics, risk factors, clinical presentation, investigational findings including electrocardiogram (EKG), echocardiogram (Echo) and cardiac magnetic resonance imaging (MRI), hospital length of stay (LOS), and outcomes in patients who developed myocarditis following administration of mRNA vaccine for COVID-19.
INFECTION CONTROL
|
|
|
12/9/21
|
Chen X, Huang Z, Wang J, et al. | BMJ Open
Aim: To estimate the rate of asymptomatic COVID-19 from published studies and compare this rate among different regions and patient groups.
CLINICAL CHARACTERISTICS
|
|
|
12/9/21
|
Tiwari S, Kc N, Thapa S, et al. | Middle East Fertil Soc J
Aim: To analyze the overall consequences of COVID-19 on semen parameters and male sex hormones. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/8/21
|
Li Y, Wei Z, Ma X, et al. | Curr Stem Cell Res
Aim: To assess the safety and efficacy of stem cell therapy for COVID-19 by providing references for subsequent clinical treatments and trials.
CANDIDATE THERAPEUTICS
|
|
|
12/8/21
|
Teoh SE, Masuda Y, Tan DJH, et al. | Ann Intensive Care
Aim: To evaluate the impact of the pandemic on the incidence and case fatality rate (CFR) of OHCA. UPDATED
|
|
|
12/8/21
|
Silva DFO, Cobucci RN, Lima SCVC, et al. | Medicine
Aim: To identify the prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
12/7/21
|
Al Maqbali M, Al Badi K, Al Sinani M, et al. | Biol Res Nurs
Aim: To identify the prevalence of the clinical symptoms of patient with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Sarkar S, Khanna P, Singh AK | Indian J Crit Care Med
Aim: To analyze the current evidence of the efficacy and safety of convalescent plasma therapy in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
12/7/21
|
Jackson WM, Price JC, Eisler L, et al. | J Neurosurg Anesthesiol
Aim: To assess the scope of diagnosis, treatment, and management of COVID-19 in pediatric patients.
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Jafari Y, Yin M, Lim C, et al. | Infect Prev Pract
Aim: To collate and assess evidence on the effectiveness of IPC interventions, excluding PPE, intended to reduce transmission of SARS-CoV-2 between patients, between patients and healthcare workers, and between healthcare workers within the hospital setting.
INFECTION CONTROL
|
|
|
12/7/21
|
Shenai MB, Rahme R, Noorchashm H | Cureus
Aim: To compare the protection of natural immunity in the COVID-recovered versus the efficacy of complete vaccination in the COVID-naive.
INFECTION CONTROL
|
|
|
12/7/21
|
Santos MO, Gonçalves LC, Silva PAN, et al. | J Pediatr
Aim: To describe the main symptoms of MIS-C and characterize its treatment and possible outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Jeyalan V, Storrar J, Wu HHL, et al. | World J Transplant
Aim: To provide an overview of the current literature on the renal histopathological features and mechanistic insights described in association with coronavirus disease 2019 (COVID-19) infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Mahmud S, Mohsin M, Dewan MN, et al. | Research Square
Aim: To examine research findings related to depression, anxiety, stress, and insomnia during the COVID-19 pandemic
MENTAL HEALTH
|
|
|
12/7/21
|
Ma C, Tu D, Gu J, et al. | Front Cardiovasc Med
Aim: To explore the predictive value of elevated Mb for adverse outcomes of patients with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/7/21
|
Sahebi A, Yousefi A, Abdi K, et al. | Front Psychiatry
Aim: To estimate the overall prevalence of PTSD among HCWs. UPDATED
MENTAL HEALTH
|
|
|
12/6/21
|
Ghahramani S, Lankarani KB, Yousefi M, et al. | Front Psychiatry
Aim: To present a comprehensive picture of the prevalence of burnout among healthcare workers during the COVID-19 pandemic. UPDATED
|
|
|
12/6/21
|
Ikeagwulonu RC, Ugwu NI, Ezeonu CT, et al. | West Afr J Med
Aim: To provide evidence that will guide clinical management by reviewing studies that assessed CRP concentration and COVID-19 severity/outcome.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
De-Miguel-Balsa E, Estevan-Ortega R, Sempere-Selva MT, et al. | Eur Rev Med Pharmacol Sci
Aim: To assess the effectiveness of colchicine, compared with standard of care, for reducing mortality, admission to intensive care, and use of mechanical ventilation.
CANDIDATE THERAPEUTICS
|
|
|
12/6/21
|
McDaniel CG, Commander SJ, DeLaura I, et al. | J Pediatr Hematol Oncol
Aim: To review the evidence on coagulation abnormalities and clinical complications in children With SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on fomites as a transmission route for COVID-19 infection.
|
|
|
12/6/21
|
Yunitri N, Chu H, Kang XL, et al. | Int J Nurs Stud
Aim: To examine the global prevalence and associated risk factors of PTSD in patients/survivors of COVID-19, health professionals, and the population at large. UPDATED
|
|
|
12/6/21
|
Ribaric NL, Vincent C, Jonitz G, et al. | Indoor Air
Aim: To identify hazards of viral dispersal and enable more precise targeting of infection prevention and control.
INFECTION CONTROL
|
|
|
12/6/21
|
Yadav DK, Adhikari VP, Ling Q, et al. | Front Med
Aim: To approximate the prognosis of LT recipients with COVID-19 on the standard maintenance IS.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
Patrucco F, Zeppegno P, Baricich A, et al. | Minerva Med
Aim: To review systematically emerging evidence about clinical and functional consequences of Covid-19 pneumonia months after hospital discharge.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on paediatric respiratory infections following lockdown and school reopening.
|
|
|
12/6/21
|
Yu T, Wang H, Zheng S, et al. | Infect Drug Resist
Aim: To perform a comprehensive review and identify clinical cases with COVID-19 complicated by CVD to establish possible demographic, clinical, laboratory patterns, and prognostic features of these cases.
CLINICAL CHARACTERISTICS
|
|
|
12/6/21
|
Mirashrafi S, Moravejolahkami AR, Balouch Zehi Z, et al. | Clin Nutr ESPEN
Aim: To conduct a rapid review of probiotics with specific emphasis on their potential for early administration in patients at greater risk of SARS-CoV-2 infection. UPDATED
|
|
|
12/6/21
|
Pu R, Liu S, Ren X, et al. | J Virols Methods
Aim: To evaluate the diagnostic accuracy of RT-PCR and RT-LAMP and the potential effects of reference methods on diagnostic accuracy.
DIAGNOSTICS
|
|
|
12/4/21
|
Decary S, Dugas M, Stefan T, et al. | SPOR
Aim: To review the evidence on care models for persons living with long COVID. UPDATED
|
|
|
12/3/21
|
Makara-Studzinska M, Zaluski M, Lickiewicz J | Psychiatria
Aim: To evaluate the mental health problems of COVID-19 survivors.
MENTAL HEALTH
|
|
|
12/3/21
|
Jaiswal V, Sarfraz Z, Sarfraz A, et al. | J Prim Care Community Health
Aim: To collate current evidence about demographics, symptomatology, diagnostic, and clinical outcomes of COVID-19 infected patients with myocarditis.
CLINICAL CHARACTERISTICS
|
|
|
12/3/21
|
Khan DSA, Hamid LR, Ali A, et al. | BMC Pregnancy Childbirth
Aim: To assess differences in risk factors, management, complications, and pregnancy and perinatal outcomes in symptomatic vs. asymptomatic pregnant women with confirmed SARS-CoV-2 infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/3/21
|
Teh JSK, Coussement J, Neoh ZCF, et al. | Blood Adv
Aim: To assess the immunogenicity and safety of COVID-19 vaccines in patients with haematological malignancy.
INFECTION CONTROL
|
|
|
12/3/21
|
Curran J, Boulos L, Somerville M, et al. | SPOR
Aim: To review the evidence on the impacts of variants of concern on public health and health systems. UPDATED
DIAGNOSTICS
|
|
|
12/2/21
|
Qomara WF, Primanissa DN, Amalia SH, et al. | Int J Gen Med
Aim: To summarize the clinical effectiveness and safety of remdesivir, favipiravir, and lopinavir/ritonavir on COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/2/21
|
Rindi LV, Moghazi SA, Donno DR, et al. | Int J Infect Dis
Aim: To summarize the literature on predicting rules for PE in hospitalized COVID-19 patients (HCPs).
CLINICAL CHARACTERISTICS
|
|
|
12/2/21
|
Pakzad R, Malekifar P, Shateri Z, et al. | J Clin Lab Anal
Aim: To evaluate the pathogens' coinfection prevalence among COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
12/1/21
|
Lin Z, Niu J, Xu Y, et al. | J Med Virol
Aim: To determine the clinical efficacy and adverse events of baricitnib in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
12/1/21
|
Granata G, Petrosillo N, Al Moghazi S, et al. | Anaerobe
Aim: To assess the proportion of confirmed COVID-19 patients with Clostridioides difficile infection (CDI) and to describe risk factors and outcome of these patients.
CLINICAL CHARACTERISTICS
|
|
|
12/1/21
|
Imtiaz S, Nafeh F, Russell C, et al. | Subst Abuse Treat Prev Policy
Aim: To review the evidence on the impact of COVID-19 on drug overdose-related deaths.
MENTAL HEALTH
|
|
|
11/30/21
|
Ismail II, Salama S | J Neuroimmunol
Aim: To systematically review the reported cases of CNS demyelination in association with COVID-19 vaccination
INFECTION CONTROL
|
|
|
11/30/21
|
Chen X | Glob Health J
Aim: To review the evidence on COVID-19 prevention, control, and treatment.
INFECTION CONTROL
|
|
|
11/30/21
|
Ahn JG | Clin Exp Pediatr
Aim: To discuss epidemiological changes in infectious diseases during the COVID-19 pandemic in Korea.
|
|
|
11/30/21
|
Siahaan YMT, Ketaren RJ, Hartoyo V, et al. | Epilepsy Behav
Aim: To analyze whether patients with epilepsy have an increased risk of having poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
|
|
|
11/30/21
|
Mazidimoradi A, Hadavandsiri F, Momenimovahed Z, et al. | J Gastrointest Cancer
Aim: To investigate the effects of COVID-19 pandemic on the diagnosis and treatment of colorectal cancer.
INFECTION CONTROL
|
|
|
11/30/21
|
Zuin M, Rigatelli G, Quadretti L, et al. | Infect Dis Rep
Aim: To assess the prevalence and mortality risk in COVID-19 patients with anemia.
CLINICAL CHARACTERISTICS
|
|
|
11/30/21
|
Eyles E, Moran P, Okolie C, et al. | J Affect Disord Rep
Aim: To review the evidence of the impact of the COVID-19 pandemic on the mental health of healthcare and social care workers, and its potential effect on suicidal thoughts and behaviour.
MENTAL HEALTH
|
|
|
11/30/21
|
Iftikhar S, Rehman AU, Ameer MZ, et al. | Ann Med Surg
Aim: To review the evidence on COVID-19-related-PRES from both clinical and pathophysiological standpoint.
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Yusof W, Irekeola AA, Wada Y, et al. | Life
Aim: To provide a global mutational profile of SARS-CoV-2 from December 2019 to October 2020. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Torres Neto L, Monteiro MLG, Galvan D, et al. | Pharmaceuticals
Aim: To identify the most promising EO compounds and potential EO sources against COVID-19 based on their affinity by target proteins, drug-likeness, bioactivity score, and ADME/T.
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Ciuffreda G, Cabanillas-Barea S, Carrasco-Uribarren A, et al. | Int J Environ Res Public Health
Aim: To explore the possible factors associated with depression and anxiety during the COVID-19 pandemic in a population older than 60 years.
MENTAL HEALTH
|
|
|
11/29/21
|
Vargas M, Marra A, Buonanno P, et al. | J Clin Med
Aim: To investigate the impact of corticosteroids on mortality in ARDS in both COVID-19 and non-COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Hussain S, Riad A, Singh A, et al. | J Fungi
Aim: To compute the pooled prevalence of CAM and other associated clinical outcomes.
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Sagris D, Florentin M, Tasoudis P, et al. | J Clin Med
Aim: To investigate the potential beneficial effect of immunomodulation therapy on the thromboembolic risk in hospitalized COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Yu M, Wang DC, Li S, et al. | J Med Virol
Aim: To systematically evaluate the efficacy and safety of Arbidol and lopinavir/ritonavir (LPV/r) in the treatment of coronavirus disease 2019(COVID-19) using a meta-analysis method.
CANDIDATE THERAPEUTICS
|
|
|
11/29/21
|
Wu HHL, Kalra PA, Chinnadurai R | Vaccines
Aim: To delineate the range of kidney histopathologies that were elicited following COVID-19 vaccination. UPDATED
INFECTION CONTROL
|
|
|
11/29/21
|
Lieneck C, Ramamonjiarivelo Z, Cox J, et al. | Healthcare
Aim: To systematically identify the facilitators and barriers experienced by outpatient health care organizations in an effort to maintain effective and efficient patient throughput during the pandemic.
INFECTION CONTROL
|
|
|
11/29/21
|
Etemadifar M, Nouri H, Maracy MR, et al. | Rev Neurol
Aim: To gather, synthesize, and meta-analyze data regarding the risk factors associated with a severe course of COVID-19 among patients with multiple sclerosis (pwMS).
CLINICAL CHARACTERISTICS
|
|
|
11/29/21
|
Hayawi K, Shahriar S, Serhani MA, et al. | Vaccines
Aim: To compare the efficacy of COVID-19 vaccines against new variants.
INFECTION CONTROL
|
|
|
11/26/21
|
Khanijahani A, Iezadi S, Gholipour K, et al. | Int J Equity Health
Aim: To systematically review the evidence on the association of racial/ethnic and socioeconomic status (SES) with health outcomes and access to healthcare services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
11/26/21
|
Santura I, Kawalec P, Furman M, et al. | Pol J Radiol
Aim: To compare chest CT diagnostic test parameters with RT-PCR (reference) in the early diagnosis of COVID-19.
DIAGNOSTICS
|
|
|
11/25/21
|
Kim HB, Kim JH, Wolf BJ | Eur j Clin Pharmacol
Aim: To exhaustively demonstrate the effect of acid suppression treatments on the risk of COVID-19.
INFECTION CONTROL
|
|
|
11/25/21
|
Rotshild V, Hirsh-Raccah B, Miskin I, et al. | Sci Rep
Aim: To compare the efficacy of new COVID-19 vaccines to prevent symptomatic and severe disease in the adult population and to prevent symptomatic COVID-19 among the elderly. UPDATED
INFECTION CONTROL
|
|
|
11/25/21
|
Iezadi S, Gholipour K, Azami-Aghdash S, et al. | PLoS ONE
Aim: To examine the effects of NPHIs on the COVID-19 case growth rate, death growth rate, Intensive Care Unit (ICU) admission, and reproduction number in countries, where NPHIs have been implemented. UPDATED
INFECTION CONTROL
|
|
|
11/25/21
|
Zhang C, Chu H, Pei YV, et al. | Front Glob Womens Health
Aim: To evaluate the effects of COVID-19 among SARS-CoV-2-positive pregnant women in late pregnancy and neonates with SARS-CoV-2-positive pregnant mothers using blood assays to find indicators of maternal and neonatal complications.
CLINICAL CHARACTERISTICS
|
|
|
11/25/21
|
Behnood SA, Shafran R, Bennett SD, et al. | J Infect
Aim: To estimate the prevalence of persistent symptoms following SARS-CoV-2 infection compared with uninfected controls and to identify potential risk factors associated with development of post-COVID symptoms in CYP.
CLINICAL CHARACTERISTICS
|
|
|
11/25/21
|
Senia P, Vella F, Mucci N, et al. | Exp Ther Med
Aim: To analyze the causes of mortality associated with SARS-CoV-2 infection in general, with particular focus on the result of infection in a professional environment.
CLINICAL CHARACTERISTICS
|
|
|
11/24/21
|
Acuff SF, Strickland JC, Tucker JA, et al. | Psychol Addict Behav
Aim: To examine changes in alcohol consumption during the coronavirus disease (COVID-19) pandemic. UPDATED
|
|
|
11/24/21
|